Education/CredentialsPostdoctoral Research: University of Cincinnati (Pharmacology and Cell Biophysics)Postdoctoral Research: University of IllinoisPostdoctoral Research: University of IowaDoctoral Degree: University of Exeter (Chemistry)Bachelor's Degree: University of Sri Lanka (Chemistry) Contact Information Email balasua@ucmail.uc.edu Research InterestsPharmacology of Neurogastrointestinal Hormones Peer Reviewed Publications Balasubramaniam, Ambikaipakan; Sheriff, Sulaiman; Friend, Lou Ann; James, J Howard 2018. Phosphodiesterase (PDE) 4B Knock-out Prevents Skeletal Muscle Atrophy in Rats with Burn Injury. American journal of physiology. Regulatory, integrative and comparative physiology, , Parker, Michael S; Balasubramaniam, Ambikaipakan; Parker, Steven L 2018. The Expansion Segments of Human 28S rRNA Match MicroRNAs Much Above 18S rRNA or Core Segments. MicroRNA (Shariqah, United Arab Emirates), 7 2, 128-137Parker, Michael S; Balasubramaniam, Ambikaipakan; Sallee, Floyd R; Parker, Steven L 2018. The Expansion Segments of 28S Ribosomal RNA Extensively Match Human Messenger RNAs. Frontiers in genetics, 9 , 66Parker, Michael S; Balasubramaniam, Ambikaipakan; Sallee, Floyd R; Parker, Steven L 2017. Canonical microRNA matching differs greatly across groups of G-protein coupled receptor mRNAs. MicroRNA (Shariqah, United Arab Emirates), , Portelli, Jeanelle; Meurs, Alfred; Bihel, Frederic; Hammoud, Hassan; Schmitt, Martine; De Kock, Joery; Utard, Valerie; Humbert, Jean-Paul; Bertin, Isabelle; Buffel, Ine; Coppens, Jessica; Tourwe, Dirk; Maes, Veronique; De Prins, An; Vanhaecke, Tamara; Massie, Ann; Balasubramaniam, Ambikaipakan; Boon, Paul; Bourguignon, Jean-Jacques; Simonin, Frederic; Smolders, Ilse 2015. Neuropeptide FF receptors as novel targets for limbic seizure attenuation. Neuropharmacology, 95 , 415-23Joshi, Rashika; Kadeer, Nijiati; Sheriff, Sulaiman; Friend, Lou Ann; James, J Howard; Balasubramaniam, Ambikaipakan 2014. Phosphodiesterase (PDE) inhibitor torbafylline (HWA 448) attenuates burn-induced rat skeletal muscle proteolysis through the PDE4/cAMP/EPAC/PI3K/Akt pathway. Molecular and cellular endocrinology, 393 1-2, 152-63Parker, Michael S; Sah, Renu; Balasubramaniam, Ambikaipakan; Park, Edwards A; Sallee, Floyd R; Parker, Steven L 2014. Dimers of G-protein coupled receptors as versatile storage and response units. International journal of molecular sciences, 15 3, 4856-77Parker, Michael S; Sah, Renu; Balasubramaniam, Ambikaipakan; Sallee, Floyd R; Park, Edwards A; Parker, Steven L 2014. On the expansion of ribosomal proteins and RNAs in eukaryotes. Amino acids, 46 7, 1589-604Sheriff, Sulaiman; Kadeer, Nijiati; Friend, Lou Ann; James, J Howard; Alexander, J Wesley; Balasubramaniam, Ambikaipakan 2014. Des-acyl-ghrelin (DAG) normalizes hyperlactacidemia and improves survival in a lethal rat model of burn trauma. Peptides, 60 , 1-7Meurs, Alfred; Portelli, Jeanelle; Clinckers, Ralph; Balasubramaniam, Ambikaipakan; Michotte, Yvette; Smolders, Ilse 2012. Neuropeptide Y increases in vivo hippocampal extracellular glutamate levels through Y1 receptor activation. Neuroscience letters, 510 2, 143-7Parker, Michael S; Balasubramaniam, Ambikaipakan; Parker, Steven L 2012. On the segregation of protein ionic residues by charge type. Amino acids, 43 6, 2231-47Sheriff, Sulaiman; Kadeer, Nijiati; Joshi, Rashika; Friend, Lou Ann; James, J Howard; Balasubramaniam, Ambikaipakan 2012. Des-acyl ghrelin exhibits pro-anabolic and anti-catabolic effects on C2C12 myotubes exposed to cytokines and reduces burn-induced muscle proteolysis in rats. Molecular and cellular endocrinology, 351 2, 286-95Watanabe, Miki; Sheriff, Sulaiman; Lewis, Kenneth B; Cho, Junho; Tinch, Stuart L; Balasubramaniam, Ambikaipakan; Kennedy, Michael A 2012. Metabolic Profiling Comparison of Human Pancreatic Ductal Epithelial Cells and Three Pancreatic Cancer Cell Lines using NMR Based Metabonomics. Journal of molecular biomarkers & diagnosis, 3 2, Watanabe, Miki; Sheriff, Sulaiman; Lewis, Kenneth B; Tinch, Stuart L; Cho, Junho; Balasubramaniam, Ambikaipakan; Kennedy, Michael A 2012. HMGA-targeted phosphorothioate DNA aptamers increase sensitivity to gemcitabine chemotherapy in human pancreatic cancer cell lines. Cancer letters, 315 1, 18-27Estes, Anne-Marie; McAllen, Kathleen; Parker, Michael S; Sah, Renu; Sweatman, Trevor; Park, Edwards A; Balasubramaniam, Ambikaipakan; Sallee, Floyd R; Walker, Mary W; Parker, Steven L 2011. Maintenance of Y receptor dimers in epithelial cells depends on interaction with G-protein heterotrimers. Amino acids, 40 2, 371-80Li, Jiang-Bo; Asakawa, Akihiro; Terashi, Mutsumi; Cheng, KaiChun; Chaolu, Huhe; Zoshiki, Takahiro; Ushikai, Miharu; Sheriff, Sulaiman; Balasubramaniam, Ambikaipakan; Inui, Akio 2010. Regulatory effects of Y4 receptor agonist (BVD-74D) on food intake. Peptides, 31 9, 1706-10Sheriff, Sulaiman; Ali, Marwan; Yahya, Ayesha; Haider, Khawaja H; Balasubramaniam, Ambikaipakan; Amlal, Hassane 2010. Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line. Molecular cancer research : MCR, 8 4, 604-14Wang, Yigang; Zhang, Dongsheng; Ashraf, Muhammad; Zhao, Tiemin; Huang, Wei; Ashraf, Atif; Balasubramaniam, Ambikaipakan 2010. Combining neuropeptide Y and mesenchymal stem cells reverses remodeling after myocardial infarction. American journal of physiology. Heart and circulatory physiology, 298 1, H275-86Balasubramaniam, Ambikaipakan; Joshi, Rashika; Friend, Lou Ann; James, J Howard 2009. GHRP-2 attenuates burn-induced dysfunctions in rodents. Advances in experimental medicine and biology, 611 , 571-2Balasubramaniam, Ambikaipakan; Joshi, Rashika; Su, Chunhua; Friend, Lou Ann; Sheriff, Sulaiman; Kagan, Richard J; James, J Howard 2009. Ghrelin inhibits skeletal muscle protein breakdown in rats with thermal injury through normalizing elevated expression of E3 ubiquitin ligases MuRF1 and MAFbx. American journal of physiology. Regulatory, integrative and comparative physiology, 296 4, R893-901Sheriff, Sulaiman; Joshi, Rashika; Friend, Lou Ann; James, J Howard; Balasubramaniam, Ambikaipakan 2009. Ghrelin receptor agonist, GHRP-2, attenuates burn injury-induced MuRF-1 and MAFbx expression and muscle proteolysis in rats. Peptides, 30 10, 1909-13Parker, Steven L; Parker, Michael S; Sah, Renu; Balasubramaniam, Ambikaipakan; Sallee, Floyd R 2008. Pertussis toxin induces parallel loss of neuropeptide Y Y1 receptor dimers and Gi alpha subunit function in CHO cells. European journal of pharmacology, 579 1-3, 13-25Parker, Steven L; Parker, Michael S; Wong, Ying Y; Sah, Renu; Balasubramaniam, Ambikaipakan; Sallee, Floyd 2008. Importance of a N-terminal aspartate in the internalization of the neuropeptide Y Y2 receptor. European journal of pharmacology, 594 1-3, 26-31Balasubramaniam, Ambikaipakan; Joshi, Rashika; Su, Chunhua; Friend, Lou Ann; James, J Howard 2007. Neuropeptide Y (NPY) Y2 receptor-selective agonist inhibits food intake and promotes fat metabolism in mice: combined anorectic effects of Y2 and Y4 receptor-selective agonists. Peptides, 28 2, 235-40Sah, Renu; Parker, Steven L; Sheriff, Sulaiman; Eaton, Katherine; Balasubramaniam, Ambikaipakan; Sallee, Floyd R 2007. Interaction of NPY compounds with the rat glucocorticoid-induced receptor (GIR) reveals similarity to the NPY-Y2 receptor. Peptides, 28 2, 302-9Amlal, Hassane; Faroqui, Somia; Balasubramaniam, Ambikaipakan; Sheriff, Sulaiman 2006. Estrogen up-regulates neuropeptide Y Y1 receptor expression in a human breast cancer cell line. Cancer research, 66 7, 3706-14Balasubramaniam, Ambikaipakan; Mullins, Deborra E; Lin, Shu; Zhai, Wexiu; Tao, Zhiyong; Dhawan, Vikas C; Guzzi, Mario; Knittel, James J; Slack, Katy; Herzog, Herbert; Parker, Eric M 2006. Neuropeptide Y (NPY) Y4 receptor selective agonists based on NPY(32-36): development of an anorectic Y4 receptor selective agonist with picomolar affinity. Journal of medicinal chemistry, 49 8, 2661-5Balasubramaniam, Ambikaipakan; Wood, Steve; Joshi, Rashika; Su, Chunhua; Friend, Lou Ann; Sheriff, Sulaiman; James, J Howard 2006. Ghrelin stimulates food intake and growth hormone release in rats with thermal injury: synthesis of ghrelin. Peptides, 27 7, 1624-31Chance, William T; Sheriff, Sulaiman; Dayal, Ramesh; Friend, Lou Ann; Thomas, Ingrid; Balasubramaniam, Ambikaipakan 2006. The role of polyamines in glucagon-like peptide-2 prevention of TPN-induced gut hypoplasia. Peptides, 27 4, 883-92Parker, Michael S; Sah, Renu; Balasubramaniam, Ambikaipakan; Parker, Steven L 2005. Lithium inhibits internalization and endosomal processing of both neuropeptide Y (NPY) Y1 and transferrin receptors. Neuroscience letters, 374 1, 43-6Sah, Renu; Balasubramaniam, Ambikaipakan; Parker, Michael S; Sallee, Floyd; Parker, Steven L 2005. Neuropeptide Y as a partial agonist of the Y1 receptor. European journal of pharmacology, 525 1-3, 60-8Balasubramaniam, Ambikaipakan 2003. Neuropeptide Y (NPY) family of hormones: progress in the development of receptor selective agonists and antagonists. Current pharmaceutical design, 9 15, 1165-75Chance, William T; Sheriff, Sulaiman; Dayal, Rameshewar; Balasubramaniam, Ambikaipakan 2003. Refractory hypothalamic alpha-mSH satiety and AGRP feeding systems in rats bearing MCA sarcomas. Peptides, 24 12, 1909-19Jois, Seetharama D S; Balasubramaniam, Ambikaipakan 2003. Conformation of neuropeptide Y receptor antagonists: structural implications in receptor selectivity. Peptides, 24 7, 1035-43Parker, Steven L; Parker, Michael S; Buschauer, Armin; Balasubramaniam, Ambikaipakan 2003. Ligand internalization by cloned neuropeptide Y Y5 receptors excludes Y2 and Y4 receptor-selective peptides. European journal of pharmacology, 474 1, 31-42Balasubramaniam, Ambikaipakan 2002. Clinical potentials of neuropeptide Y family of hormones. American journal of surgery, 183 4, 430-4Balasubramaniam, Ambikaipakan; Sheriff, Sulaiman; Zhai, Weixu; Chance, William T 2002. Bis(31/31')[[Cys(31), Nva(34)]NPY(27-36)-NH(2)]: a neuropeptide Y (NPY) Y(5) receptor selective agonist with a latent stimulatory effect on food intake in rats. Peptides, 23 8, 1485-90Bell, David; Allen, Adrian R; Kelso, Elizabeth J; Balasubramaniam, Ambikaipakan; McDermott, Barbara J 2002. Induction of hypertrophic responsiveness of cardiomyocytes to neuropeptide Y in response to pressure overload. The Journal of pharmacology and experimental therapeutics, 303 2, 581-91Sheriff, Sulaiman; F Qureshy, Asbah; T Chance, William; Kasckow, John W; Balasubramaniam, Ambikaipakan 2002. Predominant role by CaM kinase in NPY Y(1) receptor signaling: involvement of CREB [corrected]. Peptides, 23 1, 87-96Balasubramaniam,A.; Rigel,D.F.; Chance,W.T.; Stein,M.; Fischer,J.E.; King,D.; Plisetskaya,E.M. 1990. Salmon pancreatic polypeptide exhibits neuropeptide y-like activities in rats Peptides, 11 4, 673Balasubramaniam,A.; Sheriff,S. 1990. Neuropeptide y(18-36) is a competitive antagonist of neuropeptide y in rat cardiac ventricular membranes Journal of Biological Chemistry, 265 25, 14724Balasubramaniam,A.; Sheriff,S.; Ferguson,D.G.; Stein,M.; Rigel,D.F. 1990. N-α-biotinylated-neuropeptide y analogs: syntheses, cardiovascular properties, and application to cardiac npy receptor visualization Peptides, 11 6, 1151Balasubramaniam,A.; Sheriff,S.; Renugopalakrishnan,V.; Huang,S.G.; Prabhakaran,M.; Chance,W.T.; Fischer,J.E. 1990. Cardiac properties and conformational studies of neuropeptide y (npy) and npy(17-36) Annals of the New York Academy of Sciences, 611 , 355Balasubramaniam,A.; Sheriff,S.; Rigel,D.F.; Fischer,J.E. 1990. Characterization of neuropeptide y binding sites in rat cardiac ventricular membranes Peptides, 11 3, 545Ramo,O.J.; Balasubramaniam,A.; Sheriff,S.; Rogers,D.H.; McCullough,P.J.; Bell Jr.,R.H. 1990. Neuropeptide y and peptide yy stimulate the growth of exocrine pancreatic carcinoma cells Neuropeptides, 15 2, 101Rudnicki,M.; McFadden,D.W.; Liwnicz,B.H.; Balasubramaniam,A.; Nussbaum,M.S.; Dayal,R.; Fischer,J.E. 1990. Endogenous peptide yy is dependent on jejunal exposure to gastrointestinal contents Journal of Surgical Research, 48 5, 485Sheriff,S.; Rigel,D.F.; Fischer,J.E.; Balasubramaniam,A. 1990. Interaction of 125i-neuropeptide y with rat cardiac membranes Neuropeptides, 15 3, 157Chance,W.T.; Sheriff,S.; Foley-Nelson,T.; Fischer,J.E.; Balasubramaniam,A. 1989. Pertussis toxin inhibits neuropeptide y-induced feeding in rats Peptides, 10 6, 1283Parker S.;Balasubramaniam A. 12-25-2008. Neuropeptide Y Y2 receptor in health and disease (British Journal of Pharmacology (2007) 153, (420-4 British Journal of Pharmacology, 155 8, 1307Balasubramaniam A.;Zhai W.;Tao Z.;Huang Y.;Fischer J.;Eden P.;Taylor J.;Kar L.;Samarasinghe S.;Johnson M. 12-24-1996. Synthesis, structure, and antagonistic properties of Des-Asn<sup>29</sup>[D-Trp-<sup& Peptides, 17 7, 1113-1118Parker M.;Sah R.;Sheriff S.;Balasubramaniam A.;Parker S. 12-15-2005. Internalization of cloned pancreatic polypeptide receptors is accelerated by all types of Y4 agonist Regulatory Peptides, 132 1-3, 91-101Porter J.;Balasubramaniam A.;Abel P.;Conlon J. 12-15-1994. Differential actions of lamprey peptide methionine-tyrosine at Y<inf>1</inf> and Y<in Regulatory Peptides, 54 2-3, 489-493Goumain M.;Voisin T.;Lorinet A.;Balasubramaniam A.;Laburthe M. 12-04-1998. Pharmacological profile of the rat intestinal crypt peptide YY receptor vs. the recombinant rat Y5 r European Journal of Pharmacology, 362 2-3, 245-249Parker M.;Sah R.;Balasubramaniam A.;Sallee F.;Crowley W.;Parker S. 12-01-2013. Neuropeptide y in feeding: Specific and protean actions Neuropeptide Y: Molecular Structure, Role in Food Intake and Direct/Indirect Effects, , 107-167Watanabe M.;Sheriff S.;Ramelot T.;Kadeer N.;Cho J.;Lewis K.;Balasubramaniam A.;Kennedy M. 12-01-2011. NMR based metabonomics study of DAG treatment in a C2C12 mouse skeletal muscle cell line myotube mod International Journal of Peptide Research and Therapeutics, 17 4, 281-299Parker S.;Parker M.;Sallee F.;Balasubramaniam A. 12-01-2007. Oligomerization of neuropeptide Y (NPY) Y2 receptors in CHO cells depends on functional pertussis to Regulatory Peptides, 144 1-3, 72-81Samarasinghe S.;Karl L.;Balasubramaniam A.;Johnson M. 12-01-1997. Sequence-specific <sup>1</sup>H NMR assignments and secondary structure of neuropeptide Protein and Peptide Letters, 4 4, 251-258Millar B.;McDermott B.;Piper H.;Balasubramaniam A.;Weis T. 12-01-1991. NPY-(18-36) and pertussis toxin distinguish between the negative and positive contractile effects of Advances in Experimental Medicine and Biology, 311 , 325-326Millar B.C.;Weis T.;Piper H.M.;Weber M.;Borchard U.;McDermott B.J.;Balasubramaniam A. 12-01-1991. Positive and negative contractile effects of neuropeptide Y on ventricular cardiomyocytes American Journal of Physiology - Heart and Circulatory Physiology, 261 6 30-6, McFadden D.;Rudnicki M.;Nussbaum M.;Balasubramaniam A.;Dayal R.;Fischer J. 12-01-1989. Atropine inhibits the postprandial circulating release of neuropeptide Y in conscious dogs Surgical Forum, 40 , 182-184Murphy R.;Balasubramaniam A.;Mei-Huei Chen;Cardin A.;Rayford P.;Jackson R.;Joffe S. 11-16-1984. Specificity of cholecystokinin antibody may influence choice of tracer for radioimmunoassay Journal of Immunological Methods, 74 1, 199-203Chance W.T.;Foley-Nelson T.;Thomas I.;Balasubramaniam A. 10-13-1997. Prevention of parenteral nutrition-induced gut hypoplasia by coinfusion of glucagon-like peptide-2 American Journal of Physiology - Gastrointestinal and Liver Physiology, 273 2 36-2, Estes A.M.;Wong Y.Y.;Parker M.S.;Sallee F.R.;Balasubramaniam A.;Parker S.L. 10-09-2008. Neuropeptide Y (NPY) Y2 receptors of rabbit kidney cortex are largely dimeric Regulatory Peptides, 150 1-3, 88-94Chance W.T.;Balasubramaniam A.;Thomas I.;Fischer J.E. 10-09-1992. Amylin increases transport of tyrosine and tryptophan into the brain Brain Research, 593 1, 20-24McDermott B.;Millar B.;Dolan F.;Bell D.;Balasubramaniam A. 10-08-1997. Evidence for Y<inf>1</inf> and Y<inf>2</inf> subtypes of neuropeptide Y rece European Journal of Pharmacology, 336 2-3, 257-265Wang B.;Sheriff S.;Balasubramaniam A.;Kennedy M. 10-07-2015. NMR based metabolomics study of Y2 receptor activation by neuropeptide Y in the SK-N-BE2 human neuro Metabolomics, 11 5, 1243-1252McLean L.;Best S.;Balasubramaniam A.;Jackson R. 10-03-1986. Fatty acyl chain specificity of phosphatidylcholine hydrolysis catalyzed by lipoprotein lipase. Effe Biochimica et Biophysica Acta (BBA)/Lipids and Lipid Metabolism, 878 3, 446-449Watanabe M.;Sheriff S.;Kadeer N.;Cho J.;Lewis K.;Balasubramaniam A.;Kennedy M. 10-01-2012. NMR based metabonomics study of NPY Y5 receptor activation in BT-549, a human breast carcinoma cell Metabolomics, 8 5, 854-868Shahab M.;Balasubramaniam A.;Sahu A.;Plant T. 10-01-2003. Central nervous system receptors involved in mediating the inhibitory action of neuropeptide Y on lu Journal of Neuroendocrinology, 15 10, 965-970Balasubramaniam A.;Sheriff S. 09-28-1990. Neuropeptide Y(18-36) is a competitive antagonist of neuropeptide Y in rat cardiac ventricular membr Journal of Biological Chemistry, 265 25, 14724-14727Chance W.;Sheriff S.;Kasckow J.;Regmi A.;Balasubramaniam A. 09-25-1998. NPY messenger RNA is increased in medial hypothalamus of anorectic tumor-bearing rats Regulatory Peptides, 75-76 , 347-353Sheriff S.;Dayal R.;Kasckow J.;Regmi A.;Chance W.;Fischer J.;Balasubramaniam A. 09-25-1998. NPY upregulates genes containing cyclic AMP response element in human neuroblastoma cell lines beari Regulatory Peptides, 75-76 , 309-318Chance W.;Balasubramaniam A.;Borchers M.;Fischer J. 09-11-1995. Refractory hypothalamic adenylate cyclase in anorectic tumor-bearing rats: implications for NPY-indu Brain Research, 691 1-2, 180-184Balasubramaniam A.;Tao Z.;Zhai W.;Stein M.;Sheriff S.;Chance W.;Fischer J.;Eden P.;Taylor J.;Liu C.;McFadden D.;Voisin T.;Roze C.;Laburthe M. 09-07-2000. Structure-activity studies including a ?(CH<inf>2</inf>-NH) scan of peptide YY (PYY) act Journal of Medicinal Chemistry, 43 18, 3420-3427Parker M.;Sah R.;Balasubramaniam A.;Sallee F.;Sweatman T.;Park E.;Parker S. 09-01-2008. Dimers of the neuropeptide Y (NPY) Y2 receptor show asymmetry in agonist affinity and association wi Journal of Receptors and Signal Transduction, 28 5, 437-451Balasubramaniam A. 09-01-2007. Editorial Current Topics in Medicinal Chemistry, 7 17, 1644Diccianni M.B.;Lilly-Stauderman M.;Harmony J.A.K.;McLean L.R.;Balasubramaniam A. 09-01-1991. Heparin Prevents the Binding of Phospholipase A<inf>2</inf> to Phospholipid Micelles: Im Biochemistry, 30 37, 9090-9097Balasubramaniam A.;Renugopalakrishnan V.;Rigel D.;Nussbaum M.;Rapaka R.;Dobbs J.;Carreira L.;Fischer J. 08-31-1989. Synthesis and biological properties of 4-norleucine-neuropeptide Y; secondary structure of neuropept Biochimica et Biophysica Acta (BBA)/Protein Structure and Molecular, 997 3, 176-181Chance W.;Sheriff S.;Moore J.;Peng F.;Balasubramaniam A. 08-24-1998. Reciprocal changes in hypothalamic receptor binding and circulating leptin in anorectic tumor-bearin Brain Research, 803 1-2, 27-33Chance W.;Tao Z.;Sheriff S.;Balasubramaniam A. 08-24-1998. Wryamide, a NPY-based tripeptide that antagonizes feeding in rats Brain Research, 803 1-2, 39-43McLean L.;Balasubramaniam A. 08-21-1992. Promotion of ?-structure by interaction of diabetes associated polypeptide (amylin) with phosphatidy Biochimica et Biophysica Acta (BBA)/Protein Structure and Molecular, 1122 3, 317-320Sheriff S.;Fischer J.;Balasubramaniam A. 08-12-1992. Amylin inhibits insulin-stimulated glucose uptake in C<inf>2</inf>C<inf>12</inf BBA - Molecular Cell Research, 1136 2, 219-222Sheriff S.;Qureshy A.;Chance W.;Kasckow J.;Balasubramaniam A. 07-30-2002. Erratum: Predominant role by CaM kinase in NPY Y<inf>1</inf> receptor signaling: Involve Peptides, 23 6, 1195Amoscato A.;Balasubramaniam A.;Wesley Alexander J.;Bebcock G. 07-20-1988. Degradation of thymopentin by human lymphocytes: evidence for aminopeptidase activity Biochimica et Biophysica Acta (BBA)/Protein Structure and Molecular, 955 2, 164-174Parker S.L.;Parker M.S.;Lundell I.;Balasubramaniam A.;Buschauer A.;Kane J.K.;Yalcin A.;Berglund M.M. 07-15-2002. Agonist internalization by cloned Y1 neuropeptide Y (NPY) receptor in Chinese hamster ovary cells sh Regulatory Peptides, 107 1-3, 49-62James J.H.;Wagner K.R.;King J.K.;Leffler R.E.;Upputuri R.K.;Balasubramaniam A.;Friend L.A.;Shelly D.A.;Paul R.J.;Fischer J.E. 07-01-1999. Stimulation of both aerobic glycolysis and Na<sup>+</sup>-K<sup>+</sup>-ATPa American Journal of Physiology - Endocrinology and Metabolism, 277 1 40-1, Balasubramaniam A.;Rechtin A.;McLean L.;Jackson R.;Demel R. 06-30-1986. Activation of lipoprotein lipase by N-?-palmitoyl (56-79) fragment of apolipoprotein C-II Biochemical and Biophysical Research Communications, 137 3, 1041-1048Balasubramaniam A. 06-09-1997. Neuropeptide Y family of hormones: Receptor subtypes and antagonists Peptides, 18 3, 445-457Chance W.;Balasubramaniam A.;Sheriff S. 06-04-2003. Neuropeptide Y and cancer anorexia Current Medicinal Chemistry - Central Nervous System Agents, 3 2, 127-139Chance W.;Zhang X.;Zuo L.;Balasubramaniam A. 06-01-1998. Reduction of gut hypoplasia and cachexia in tumor-bearing rats maintained on total parenteral nutrit Nutrition, 14 6, 502-507Parker E.;Babij C.;Balasubramaniam A.;Burrier R.;Guzzi M.;Hamud F.;Gitali Mukhopadhyay;Rudinski M.;Tao Z.;Tice M.;Xia L.;Mullins D.;Salisbury B. 05-15-1998. GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y European Journal of Pharmacology, 349 1, 97-105Balasubramaniam A.;Dhawan V.;Mullins D.;Chance W.;Sheriff S.;Guzzi M.;Prabhakaran M.;Parker E. 05-10-2001. Highly selective and potent neuropeptide Y (NPY) Y1 receptor antagonists based on [Pro<sup>30& Journal of Medicinal Chemistry, 44 10, 1479-1482Parker S.L.;Parker M.S.;Estes A.M.;Wong Y.Y.;Sah R.;Sweatman T.;Park E.A.;Balasubramaniam A.;Sallee F.R. 05-01-2008. The neuropeptide Y (NPY) Y2 receptors are largely dimeric in the kidney, but monomeric in the forebr Journal of Receptors and Signal Transduction, 28 3, 245-263Conlon J.M.;Balasubramaniam A.;Hazon N. 05-01-1991. Structural characterization and biological activity of a neuropeptide Y-related peptide from the dog Endocrinology, 128 5, 2273-2279Chance W.;Zhang X.;Balasubramaniam A.;Fischer J. 04-19-1996. Preservation of intestine protein by peptide YY during total parenteral nutrition Life Sciences, 58 21, 1785-1794Chance W.;Balasubramaniam A.;Stallion A.;Fischer J. 04-02-1993. Anorexia following the systemic injection of amylin Brain Research, 607 1-2, 185-188Jois S.;Nagarajarao L.;Prabhakaran M.;Balasubramaniam A. 04-01-2006. Modeling of neuropeptide receptors Y1, Y4, Y5, and docking studies with neuropeptide antagonist anal Journal of Biomolecular Structure and Dynamics, 23 5, 497-508Balasubramaniam A.;Zhai W.;Sheriff S.;Tao Z.;Chance W.;Fischer J.;Eden P.;Taylor J. 03-08-1996. Bis(31/31'){[Cys<sup>31</sup>,Trp<sup>32</sup>,Nva<sup>34</sup>] Journal of Medicinal Chemistry, 39 4, 811-813Parker M.;Balasubramaniam A.;Sallee F.;Parker S. 03-07-2018. The expansion segments of 28S Ribosomal RNA extensively match human messenger RNAs Frontiers in Genetics, 9 MAR, Parker S.;Parker M.;Sah R.;Sallee F.;Balasubramaniam A. 03-01-2007. Parallel inactivation of Y<inf>2</inf> receptor and G-proteins in CHO cells by pertussis Regulatory Peptides, 139 1-3, 128-135Parker E.;Balasubramaniam A.;Guzzi M.;Mullins D.;Salisbury B.;Sheriff S.;Witten M.;Hwa J. 03-01-2000. [D-Trp<sup>34</sup>] neuropeptide Y is a potent and selective neuropeptide Y Y<inf> Peptides, 21 3, 393-399Balasubramaniam A.;Ujhelyi M.;Borchers M.;Huang Y.;Zhai W.;Zhou Y.;Johnson M.;Sheriff S.;Fischer J.E. 03-01-1996. Antagonistic properties of centrally truncated analogs of [D-Trp<sup>32</sup>]NPY Journal of Medicinal Chemistry, 39 5, 1142-1147Balasubramaniam A.;Sheriff S.;Johnson E.;Prabhakaran M.;Huang Y.;Fischer J.;Chance W. 03-01-1994. [d-TRP<sup>32</sup>]Neuropeptide Y: A Competitive Antagonist of NPY in Rat Hypothalamus Journal of Medicinal Chemistry, 37 6, 811-815Michael Conlon J.;Balasubramaniam A.;Sower S. 02-24-1994. Purification of a neuropeptide Y-related peptide from the brain of the sea lamprey and its effect on Regulatory Peptides, 50 2, 167-175Jackson R.;Balasubramaniam A.;Murphy R.;Demel R. 02-12-1986. Interaction of synthetic peptides of apolipoprotein C-II and lipoprotein lipase at monomolecular lip Biochimica et Biophysica Acta (BBA)/Lipids and Lipid Metabolism, 875 2, 203-210Parker M.;Sah R.;Balasubramaniam A.;Sallee F.;Zerbe O.;Parker S. 02-01-2011. Non-specific binding and general cross-reactivity of y receptor agonists are correlated and should i Peptides, 32 2, 258-265Parker S.;Parker M.;Sah R.;Balasubramaniam A.;Sallee F. 02-01-2007. Self-regulation of agonist activity at the Y receptors Peptides, 28 2, 203-213Sheriff S.;Chance W.T.;Iqbal S.;Rizvi T.A.;Xiao C.;Kasckow J.W.;Balasubramaniam A. 02-01-2003. Hypothalamic administration of cAMP agonist/PKA activator inhibits both schedule feeding and NPY-ind Peptides, 24 2, 245-254Chance W.T.;Balasubramaniam A.;Zhang F.S.;Wimalawansa S.J.;Fischer J.E. 01-25-1991. Anorexia following the intrahypothalamic administration of amylin Brain Research, 539 2, 352-354Gangadhar B.P.;Jois S.D.S.;Balasubramaniam A. 01-05-2004. Convenient high yield and stereoselective synthesis of O-glycopeptides using N-?-Fmoc-Tyr/Ser[?-D-Gl Tetrahedron Letters, 45 2, 355-358Parker M.;Sah R.;Park E.;Sweatman T.;Balasubramaniam A.;Sallee F.;Parker S. 01-01-2009. Oligomerization of the heptahelical G protein coupling receptors: A case for association using trans Mini-Reviews in Medicinal Chemistry, 9 3, 329-339Parker S.;Balasubramaniam A. 01-01-2008. Neuropeptide Y Y2 receptor in health and disease British Journal of Pharmacology, 153 3, 420-431Jois S.;Nagarajarao L.;Prabhakaran M.;Balasubramaniam A. 01-01-2004. Modeling of neuropeptide receptors y1, y4, y5, and docking studies with neuropeptide antagonist anal Journal of Biomolecular Structure and Dynamics, 22 1, 497-508Goumain M.;Voisin T.;Lorinet A.;Ducroc R.;Tsocas A.;Rozé C.;Rouet-Benzineb P.;Herzog H.;Balasubramaniam A.;Laburthe M. 01-01-2001. The peptide YY-preferring receptor mediating inhibition of small intestinal secretion is a periphera Molecular Pharmacology, 60 1, 124-134Sheriff S.;Dautzenberg F.;Mulchahey J.;Pisarska M.;Hauger R.;Chance W.;Balasubramaniam A.;Kasckow J. 01-01-2001. Interaction of neuropeptide Y and corticotropin-releasing factor signaling pathways in AR-5 amygdala Peptides, 22 12, 2083-2089Chance W.;Sheriff S.;Peng F.;Balasubramaniam A. 01-01-2000. Antagonism of NPY-induced feeding by pretreatrnent with cyclic AMP response element binding protein Neuropeptides, 34 3-4, 167-172Chance W.T.;Sheriff S.;Foley-Nelson T.;Thomas I.;Balasubramaniam A. 01-01-2000. Maintaining gut integrity during parenteral nutrition of tumor-bearing rats: Effects of glucagon-lik Nutrition and Cancer, 37 2, 215-222Sheriff S.;Chance W.T.;Balasubramaniam A. 01-01-2000. Antisense oligonucleotide approach to study NPY-mediated feeding signal transduction. Methods in molecular biology (Clifton, N.J.), 153 , 103-114Litvak D.;Iseki H.;Evers B.;Greeley G.;Hellmich M.;Iwase K.;Balasubramaniam A.;Townsend C. 01-01-1999. Characterization of two novel proabsorptive peptide YY analogs, BIM- 43073D and BIM-43004C Digestive Diseases and Sciences, 44 3, 643-648Mulchahey J.;Regmi A.;Sheriff S.;Balasubramaniam A.;Kasckow J. 01-01-1999. Coordinate and divergent regulation of corticotropin-releasing factor (CRF) and CRF-binding protein Endocrinology, 140 1, 251-259Samarasinghe S.;Balasubramaniam A.;Johnson M. 01-01-1997. Proton nuclear magnetic resonance studies of the structure of neuropeptide Y and its analogs Current Medicinal Chemistry, 4 2, 151-158Sheriff S.;Chance W.;Fischer J.;Balasubramaniam A. 01-01-1997. Neuropeptide Y treatment and food deprivation increase cyclic AMP response element-binding in rat hy Molecular Pharmacology, 51 4, 597-604Souli A.;Chariot J.;Voisin T.;Presset O.;Tsocas A.;Balasubramaniam A.;Laburthe M.;Rozé C. 01-01-1997. Several receptors mediate the antisecretory effect of peptide YY, neuropeptide Y, and pancreatic pol Peptides, 18 4, 551-557Chance W.;Balasubramaniam A.;Thompson H.;Mohapatra B.;Ramo J.;Fischer J. 01-01-1996. Assessment of feeding response of tumor-bearing rats to hypothalamic injection and infusion of neuro Peptides, 17 5, 797-801Huang Y.;Fischer J.E.;Balasubramaniam A. 01-01-1996. Amylin mobilizes [Ca<sup>2+</sup>]<inf>i</inf> and stimulates the release of Peptides, 17 3, 497-502Liu C.;Rongione A.;Garvey L.;Balasubramaniam A.;McFadden D. 01-01-1996. Adjuvant hormonal treatment with peptide YY or its analog decreases human pancreatic carcinoma growt American Journal of Surgery, 171 1, 192-196Chance W.;Balasubramaniam A.;Fischer J. 01-01-1995. Neuropeptide Y and the development of cancer anorexia Annals of Surgery, 221 5, 579-589Clay M.;Anantharamaiah M.;Mistry M.;Balasubramaniam A.;Harmony J. 01-01-1995. Localization of a Domain in Apolipoprotein E with both Cytostatic and Cytotoxic Activity Biochemistry, 34 35, 11142-11151Eto B.;Boisset M.;Eden P.;Balasubramaniam A.;Desjeux J. 01-01-1995. Effects of peptide YY and its analogues on chloride ion secretion in fed and fasted rat jejunum Peptides, 16 8, 1403-1409Liu C.;Balasubramaniam A.;Saxton R.;Paiva M.;McFadden D. 01-01-1995. Human pancreatic cancer growth is inhibited by peptide YY and BIM-43004-1 Journal of Surgical Research, 58 6, 707-712Liu C.;Slice L.;Balasubramaniam A.;Walsh J.;Newton T.;Saxton R.;McFadden D. 01-01-1995. Y2 receptors decrease human pancreatic cancer growth and intracellular cyclic adenosine monophosphat Surgery, 118 2, 229-236Lui C.;Hines O.;Whang E.;Balasubramaniam A.;Newton T.;Zinner M.;Ashley S.;McFadden D. 01-01-1995. A novel synthetic analog of peptide YY, BIM-43004, given intraluminally, is proabsorptive Journal of Surgical Research, 59 1, 80-84Chance W.;Balasubramaniam A.;Dayal R.;Brown J.;Fischer J. 01-01-1994. Hypothalamic concentration and release of neuropeptide Y into microdialysates is reduced in anorecti Life Sciences, 54 24, 1869-1874Chance W.T.;Balasubramaniam A.;Sheriff S.;Fischer J.E. 01-01-1994. Possible role of neuropeptide Y in experimental cancer anorexia Advances in Experimental Medicine and Biology, 354 , 185-201Balasubramaniam A.;Cox H.;Voisin T.;Laburthe M.;Stein M.;Fischer J. 01-01-1993. Structure-activity studies of peptide YY(22-36): N-?-Ac-[Phe<sup>27</sup>]PYY(22-36), a Peptides, 14 5, 1011-1016Bjenning C.;Hazon N.;Balasubramaniam A.;Holmgren S.;Conlon J.M. 01-01-1993. Distribution and activity of dogfish NPY and peptide YY in the cardiovascular system of the common d American Journal of Physiology - Regulatory Integrative and Comparative Physiology, 264 6 33-6, Lilly-Stauderman M.;Brown T.;Balasubramaniam A.;Harmony J. 01-01-1993. Heparin releases newly synthesized cell surface-associated apolipoprotein E from HepG2 cells Journal of Lipid Research, 34 2, 190-200Wadhwa S.;Jotwani G.;Balasubramaniam A. 01-01-1993. Development of neuropeptide Y-like immunoreactivity in the rat heart Acta Histochemica et Cytochemica, 26 3, 227-232Balasubramaniam A.;Rigel D.;Chance W.;Fischer J. 01-01-1992. Central and peripheral effects of sculpin pancreatic polypeptide and anglerfish peptide Y in rats. Peptide research, 5 2, 106-109Chance W.;Balasubramaniam A.;Chen X.;Fischer J. 01-01-1992. Tests of adipsia and conditioned taste aversion following the intrahypothalamic injection of amylin Peptides, 13 5, 961-964Inui A.;Okita M.;Miura M.;Hirosue Y.;Nakajima M.;Shii K.;Baba S.;Balasubramaniam A.;Kasuga M. 01-01-1992. Solubilization of high affinity peptide-YY receptors from porcine brain Endocrinology, 130 4, 2120-2128Sheriff S.;Balasubramaniam A. 01-01-1992. Inhibitory and stimulatory effects of neuropeptide Y(17-36) on rat cardiac adenylate cyclase activit Journal of Biological Chemistry, 267 7, 4680-4685Sheriff S.;Fischer J.;Balasubramaniam A. 01-01-1992. Characterization of amylin binding sites in a human hepatoblastoma cell line Peptides, 13 6, 1193-1199Balasubramaniam A.;Renugopalakrishnan V.;Stein M.;Fischer J.;Chance W. 01-01-1991. Syntheses, structures and anorectic effects of human and rat amylin Peptides, 12 5, 919-924Mcfadden D.;Rudnicki M.;Balasubramaniam A.;Fischer J. 01-01-1991. Intraluminal Heal Recovery of Pancreatic Polypeptide Archives of Surgery, 126 8, 1032-1035Balasubramaniam A.;Rigel D.F.;Chance W.T.;Stein M.;Fischer J.E.;King D.;Plisetskaya E.M. 01-01-1990. Salmon pancreatic polypeptide exhibits neuropeptide Y-like activities in rats Peptides, 11 4, 673-677Balasubramaniam A.;Sheriff S.;Ferguson D.G.;Stein M.;Rigel D.F. 01-01-1990. N-?-biotinylated-neuropeptide Y analogs: Syntheses, cardiovascular properties, and application to ca Peptides, 11 6, 1151-1156BALASUBRAMANIAM A.;SHERIFF S.;RENUGOPALAKRISHNAN V.;HUANG S.;PRABHAKARAN M.;CHANCE W.;FISCHER J. 01-01-1990. Cardiac Properties and Conformational Studies of Neuropeptide Y (NPY) and NPY(17–36) Annals of the New York Academy of Sciences, 611 1, 355-358Balasubramaniam A.;Sheriff S.;Rigel D.F.;Fischer J.E. 01-01-1990. Characterization of neuropeptide Y binding sites in rat cardiac ventricular membranes Peptides, 11 3, 545-550CHANCE W.T.;RAMO J.;SHERIFF S.;ZHANG F.;FISCHER J.E.;BALASUBRAMANIAM A. 01-01-1990. Reduction of Neuropeptide Y?Induced Feeding in Tumor?Bearing Rats Annals of the New York Academy of Sciences, 611 1, 497-499Rämö O.;Balasubramaniam A.;Sheriff S.;Rogers D.;McCullough P.;Bell R. 01-01-1990. Neuropeptide Y and peptide YY stimulate the growth of exocrine pancreatic carcinoma cells Neuropeptides, 15 2, 101-106Rudnicki M.;McFadden D.;Balasubramaniam A.;Nussbaum M.;Fischer J. 01-01-1990. The postprandial circulatory and lleal intraluminal release of neuropeptide Y in conscious dogs Journal of Surgical Research, 49 6, 514-518RUDNICKI M.;McFADDEN D.;BALASUBRAMANIAM A.;NUSSBAUM M.;FISCHER J. 01-01-1990. Neuropeptide Y and Anglerfish Peptide Amide Inhibit Secretin?Stimulated Pancreatic Exocrine Secretio Annals of the New York Academy of Sciences, 611 1, 423-425Rudnicki M.;McFadden D.;Liwnicz B.;Balasubramaniam A.;Nussbaum M.;Dayal R.;Fischer J. 01-01-1990. Endogenous peptide YY is dependent on jejunal exposure to gastrointestinal contents Journal of Surgical Research, 48 5, 485-490Rudnicki M.;Patel D.G.;McFadden D.W.;Balasubramaniam A.;Nussbaum M.S.;Fischer J.E. 01-01-1990. Proximal jejunal and biliary effects on the enteroinsular axis Surgery, 107 4, 455-460Sheriff S.;Rigel D.;Fischer J.;Balasubramaniam A. 01-01-1990. Interaction of <sup>125</sup>I-Neuropeptide Y with rat cardiac membranes Neuropeptides, 15 3, 157-160Balasubramaniam A.;Andrews P.C.;Renugopalakrishnan V.;Rigel D.F. 01-01-1989. Glycine-extended anglerfish peptide YG (aPY) a neuropeptide Y (NPY) homologue may be a precursor of Peptides, 10 3, 581-585BALASUBRAMANIAM A.;KNITTEL J.J.;GILL C.;ANDREWS P.C. 01-01-1989. Detection of conformational isomers of anglerfish peptide YG (aPY) by reversed phase chromatography International Journal of Peptide and Protein Research, 34 2, 158-160Balasubramaniam A.;McFadden D.;Rudnicki M.;Nussbaum M.;Dayal R.;Srivastava L.;Fischer J. 01-01-1989. Radioimmunoassay to determine postprandial changes in plasma Neuropeptide Y levels in awake dogs Neuropeptides, 14 3, 209-212Chance W.T.;Sheriff S.;Foley-Nelson T.;Fischer J.E.;Balasubramaniam A. 01-01-1989. Pertussis toxin inhibits neuropeptide Y-induced feeding in rats Peptides, 10 6, 1283-1286McFadden D.;Rudnicki M.;Nussbaum M.;Balasubramaniam A.;Fischer J. 01-01-1989. Independent release of peptide YY (PYY) into the circulation and ileal lumen of the awake dog Journal of Surgical Research, 46 4, 380-385Milgram S.;Balasubramaniam A.;Andrews P.;McDonald J.;Noe B. 01-01-1989. Characterization of aPY-like peptides in anglerfish brain using a novel radioimmunoassay for aPY-Gly Peptides, 10 5, 1013-1017Noe B.;Milgram S.;Balasubramaniam A.;Andrews P.;Calka J.;McDonald J. 01-01-1989. Localization and characterization of neuropeptide Y-like peptides in the brain and islet organ of th Cell and Tissue Research, 257 2, 303-311Renugopalakrishnan V.;Prabhakaran M.;Huang S.;Balasubramaniam A.;Strawich E.;Glimcher M. 01-01-1989. Secondary structure and limited three-dimensional structure of bovine amelogenin Connective Tissue Research, 22 1-4, 757-764Rigel D.;Grupp I.;Balasubramaniam A.;Grupp G. 01-01-1989. Contractile effects of cardiac neuropeptides in isolated canine atrial and ventricular muscles American Journal of Physiology - Heart and Circulatory Physiology, 257 4, Servin A.L.;Rouyer-Fessard C.;Balasubramaniam A.;Pierre S.S.;Laburthe M. 01-01-1989. Peptide-yy and neuropeptide-y inhibit vasoactive intestinal peptide-stimulated adenosine 3', 5'-mono Endocrinology, 124 2, 692-700Balasubramaniam A.;Grupp I.;Matlib M.;Benza R.;Jackson R.;Fischer J.;Grupp G. 01-01-1988. Comparison of the effects of neuropeptide Y (NPY) and 4-norleucine-NPY on isolated perfused rat hear Regulatory Peptides, 21 3-4, 289-299Balasubramaniam A.;Servin A.L.;Rigel D.F.;Rouyer-Fessard C.R.;Laburthe M. 01-01-1988. Syntheses and receptor affinities of partial sequences of peptide YY (PYY). Peptide research, 1 1, 32-35McFadden D.;Nussbaum M.;Rudnicki M.;Balasubramaniam A.;Fischer J. 01-01-1988. Postprandial neuropeptide Y release in the conscious dog Surgical Forum, 39 , 143-145Balasubramaniam A.;Chopra Y.;Yates M.;Jackson R. 01-01-1987. Total synthesis of human plasma apolipoprotein C-II Bioorganic Chemistry, 15 2, 141-151BALASUBRAMANIAM A.;GRUPP I.;SRIVASTAVA L.;TATEMOTO K.;MURPHY R.F.;JOFFE S.N.;FISCHER J.E. 01-01-1987. Synthesis of neuropeptide Y International Journal of Peptide and Protein Research, 29 1, 78-83Clark J.;Sahu A.;Kalra P.;Balasubramaniam A.;Kalra S. 01-01-1987. Neuropeptide Y (NPY)-induced feeding behavior in female rats: comparison with human NPY ([Met<sup Regulatory Peptides, 17 1, 31-39Sahu A.;Crowley W.;Tatemoto K.;Balasubramaniam A.;Kalra S. 01-01-1987. Effects of neuropeptide Y, NPY analog (norleucine<sup>4</sup>-NPY), galanin and neuropep Peptides, 8 5, 921-926Balasubramaniam A.;Demel R.;Murphy R.;Sparrow J.;Jackson R. 01-01-1986. Substitution of SER<inf>61</inf> ? GLY<inf>61</inf> in human apolipoprotein Chemistry and Physics of Lipids, 39 4, 341-346BALASUBRAMANIAM A.;MURPHY R.;BLUMENTHAL K. 01-01-1986. Synthesis of sequences 1–16 and 63–95 of Cerebratulus lacteus toxin AIII: Hemolytic activity in a to International Journal of Peptide and Protein Research, 27 5, 508-513
Peer Reviewed Publications Balasubramaniam, Ambikaipakan; Sheriff, Sulaiman; Friend, Lou Ann; James, J Howard 2018. Phosphodiesterase (PDE) 4B Knock-out Prevents Skeletal Muscle Atrophy in Rats with Burn Injury. American journal of physiology. Regulatory, integrative and comparative physiology, , Parker, Michael S; Balasubramaniam, Ambikaipakan; Parker, Steven L 2018. The Expansion Segments of Human 28S rRNA Match MicroRNAs Much Above 18S rRNA or Core Segments. MicroRNA (Shariqah, United Arab Emirates), 7 2, 128-137Parker, Michael S; Balasubramaniam, Ambikaipakan; Sallee, Floyd R; Parker, Steven L 2018. The Expansion Segments of 28S Ribosomal RNA Extensively Match Human Messenger RNAs. Frontiers in genetics, 9 , 66Parker, Michael S; Balasubramaniam, Ambikaipakan; Sallee, Floyd R; Parker, Steven L 2017. Canonical microRNA matching differs greatly across groups of G-protein coupled receptor mRNAs. MicroRNA (Shariqah, United Arab Emirates), , Portelli, Jeanelle; Meurs, Alfred; Bihel, Frederic; Hammoud, Hassan; Schmitt, Martine; De Kock, Joery; Utard, Valerie; Humbert, Jean-Paul; Bertin, Isabelle; Buffel, Ine; Coppens, Jessica; Tourwe, Dirk; Maes, Veronique; De Prins, An; Vanhaecke, Tamara; Massie, Ann; Balasubramaniam, Ambikaipakan; Boon, Paul; Bourguignon, Jean-Jacques; Simonin, Frederic; Smolders, Ilse 2015. Neuropeptide FF receptors as novel targets for limbic seizure attenuation. Neuropharmacology, 95 , 415-23Joshi, Rashika; Kadeer, Nijiati; Sheriff, Sulaiman; Friend, Lou Ann; James, J Howard; Balasubramaniam, Ambikaipakan 2014. Phosphodiesterase (PDE) inhibitor torbafylline (HWA 448) attenuates burn-induced rat skeletal muscle proteolysis through the PDE4/cAMP/EPAC/PI3K/Akt pathway. Molecular and cellular endocrinology, 393 1-2, 152-63Parker, Michael S; Sah, Renu; Balasubramaniam, Ambikaipakan; Park, Edwards A; Sallee, Floyd R; Parker, Steven L 2014. Dimers of G-protein coupled receptors as versatile storage and response units. International journal of molecular sciences, 15 3, 4856-77Parker, Michael S; Sah, Renu; Balasubramaniam, Ambikaipakan; Sallee, Floyd R; Park, Edwards A; Parker, Steven L 2014. On the expansion of ribosomal proteins and RNAs in eukaryotes. Amino acids, 46 7, 1589-604Sheriff, Sulaiman; Kadeer, Nijiati; Friend, Lou Ann; James, J Howard; Alexander, J Wesley; Balasubramaniam, Ambikaipakan 2014. Des-acyl-ghrelin (DAG) normalizes hyperlactacidemia and improves survival in a lethal rat model of burn trauma. Peptides, 60 , 1-7Meurs, Alfred; Portelli, Jeanelle; Clinckers, Ralph; Balasubramaniam, Ambikaipakan; Michotte, Yvette; Smolders, Ilse 2012. Neuropeptide Y increases in vivo hippocampal extracellular glutamate levels through Y1 receptor activation. Neuroscience letters, 510 2, 143-7Parker, Michael S; Balasubramaniam, Ambikaipakan; Parker, Steven L 2012. On the segregation of protein ionic residues by charge type. Amino acids, 43 6, 2231-47Sheriff, Sulaiman; Kadeer, Nijiati; Joshi, Rashika; Friend, Lou Ann; James, J Howard; Balasubramaniam, Ambikaipakan 2012. Des-acyl ghrelin exhibits pro-anabolic and anti-catabolic effects on C2C12 myotubes exposed to cytokines and reduces burn-induced muscle proteolysis in rats. Molecular and cellular endocrinology, 351 2, 286-95Watanabe, Miki; Sheriff, Sulaiman; Lewis, Kenneth B; Cho, Junho; Tinch, Stuart L; Balasubramaniam, Ambikaipakan; Kennedy, Michael A 2012. Metabolic Profiling Comparison of Human Pancreatic Ductal Epithelial Cells and Three Pancreatic Cancer Cell Lines using NMR Based Metabonomics. Journal of molecular biomarkers & diagnosis, 3 2, Watanabe, Miki; Sheriff, Sulaiman; Lewis, Kenneth B; Tinch, Stuart L; Cho, Junho; Balasubramaniam, Ambikaipakan; Kennedy, Michael A 2012. HMGA-targeted phosphorothioate DNA aptamers increase sensitivity to gemcitabine chemotherapy in human pancreatic cancer cell lines. Cancer letters, 315 1, 18-27Estes, Anne-Marie; McAllen, Kathleen; Parker, Michael S; Sah, Renu; Sweatman, Trevor; Park, Edwards A; Balasubramaniam, Ambikaipakan; Sallee, Floyd R; Walker, Mary W; Parker, Steven L 2011. Maintenance of Y receptor dimers in epithelial cells depends on interaction with G-protein heterotrimers. Amino acids, 40 2, 371-80Li, Jiang-Bo; Asakawa, Akihiro; Terashi, Mutsumi; Cheng, KaiChun; Chaolu, Huhe; Zoshiki, Takahiro; Ushikai, Miharu; Sheriff, Sulaiman; Balasubramaniam, Ambikaipakan; Inui, Akio 2010. Regulatory effects of Y4 receptor agonist (BVD-74D) on food intake. Peptides, 31 9, 1706-10Sheriff, Sulaiman; Ali, Marwan; Yahya, Ayesha; Haider, Khawaja H; Balasubramaniam, Ambikaipakan; Amlal, Hassane 2010. Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line. Molecular cancer research : MCR, 8 4, 604-14Wang, Yigang; Zhang, Dongsheng; Ashraf, Muhammad; Zhao, Tiemin; Huang, Wei; Ashraf, Atif; Balasubramaniam, Ambikaipakan 2010. Combining neuropeptide Y and mesenchymal stem cells reverses remodeling after myocardial infarction. American journal of physiology. Heart and circulatory physiology, 298 1, H275-86Balasubramaniam, Ambikaipakan; Joshi, Rashika; Friend, Lou Ann; James, J Howard 2009. GHRP-2 attenuates burn-induced dysfunctions in rodents. Advances in experimental medicine and biology, 611 , 571-2Balasubramaniam, Ambikaipakan; Joshi, Rashika; Su, Chunhua; Friend, Lou Ann; Sheriff, Sulaiman; Kagan, Richard J; James, J Howard 2009. Ghrelin inhibits skeletal muscle protein breakdown in rats with thermal injury through normalizing elevated expression of E3 ubiquitin ligases MuRF1 and MAFbx. American journal of physiology. Regulatory, integrative and comparative physiology, 296 4, R893-901Sheriff, Sulaiman; Joshi, Rashika; Friend, Lou Ann; James, J Howard; Balasubramaniam, Ambikaipakan 2009. Ghrelin receptor agonist, GHRP-2, attenuates burn injury-induced MuRF-1 and MAFbx expression and muscle proteolysis in rats. Peptides, 30 10, 1909-13Parker, Steven L; Parker, Michael S; Sah, Renu; Balasubramaniam, Ambikaipakan; Sallee, Floyd R 2008. Pertussis toxin induces parallel loss of neuropeptide Y Y1 receptor dimers and Gi alpha subunit function in CHO cells. European journal of pharmacology, 579 1-3, 13-25Parker, Steven L; Parker, Michael S; Wong, Ying Y; Sah, Renu; Balasubramaniam, Ambikaipakan; Sallee, Floyd 2008. Importance of a N-terminal aspartate in the internalization of the neuropeptide Y Y2 receptor. European journal of pharmacology, 594 1-3, 26-31Balasubramaniam, Ambikaipakan; Joshi, Rashika; Su, Chunhua; Friend, Lou Ann; James, J Howard 2007. Neuropeptide Y (NPY) Y2 receptor-selective agonist inhibits food intake and promotes fat metabolism in mice: combined anorectic effects of Y2 and Y4 receptor-selective agonists. Peptides, 28 2, 235-40Sah, Renu; Parker, Steven L; Sheriff, Sulaiman; Eaton, Katherine; Balasubramaniam, Ambikaipakan; Sallee, Floyd R 2007. Interaction of NPY compounds with the rat glucocorticoid-induced receptor (GIR) reveals similarity to the NPY-Y2 receptor. Peptides, 28 2, 302-9Amlal, Hassane; Faroqui, Somia; Balasubramaniam, Ambikaipakan; Sheriff, Sulaiman 2006. Estrogen up-regulates neuropeptide Y Y1 receptor expression in a human breast cancer cell line. Cancer research, 66 7, 3706-14Balasubramaniam, Ambikaipakan; Mullins, Deborra E; Lin, Shu; Zhai, Wexiu; Tao, Zhiyong; Dhawan, Vikas C; Guzzi, Mario; Knittel, James J; Slack, Katy; Herzog, Herbert; Parker, Eric M 2006. Neuropeptide Y (NPY) Y4 receptor selective agonists based on NPY(32-36): development of an anorectic Y4 receptor selective agonist with picomolar affinity. Journal of medicinal chemistry, 49 8, 2661-5Balasubramaniam, Ambikaipakan; Wood, Steve; Joshi, Rashika; Su, Chunhua; Friend, Lou Ann; Sheriff, Sulaiman; James, J Howard 2006. Ghrelin stimulates food intake and growth hormone release in rats with thermal injury: synthesis of ghrelin. Peptides, 27 7, 1624-31Chance, William T; Sheriff, Sulaiman; Dayal, Ramesh; Friend, Lou Ann; Thomas, Ingrid; Balasubramaniam, Ambikaipakan 2006. The role of polyamines in glucagon-like peptide-2 prevention of TPN-induced gut hypoplasia. Peptides, 27 4, 883-92Parker, Michael S; Sah, Renu; Balasubramaniam, Ambikaipakan; Parker, Steven L 2005. Lithium inhibits internalization and endosomal processing of both neuropeptide Y (NPY) Y1 and transferrin receptors. Neuroscience letters, 374 1, 43-6Sah, Renu; Balasubramaniam, Ambikaipakan; Parker, Michael S; Sallee, Floyd; Parker, Steven L 2005. Neuropeptide Y as a partial agonist of the Y1 receptor. European journal of pharmacology, 525 1-3, 60-8Balasubramaniam, Ambikaipakan 2003. Neuropeptide Y (NPY) family of hormones: progress in the development of receptor selective agonists and antagonists. Current pharmaceutical design, 9 15, 1165-75Chance, William T; Sheriff, Sulaiman; Dayal, Rameshewar; Balasubramaniam, Ambikaipakan 2003. Refractory hypothalamic alpha-mSH satiety and AGRP feeding systems in rats bearing MCA sarcomas. Peptides, 24 12, 1909-19Jois, Seetharama D S; Balasubramaniam, Ambikaipakan 2003. Conformation of neuropeptide Y receptor antagonists: structural implications in receptor selectivity. Peptides, 24 7, 1035-43Parker, Steven L; Parker, Michael S; Buschauer, Armin; Balasubramaniam, Ambikaipakan 2003. Ligand internalization by cloned neuropeptide Y Y5 receptors excludes Y2 and Y4 receptor-selective peptides. European journal of pharmacology, 474 1, 31-42Balasubramaniam, Ambikaipakan 2002. Clinical potentials of neuropeptide Y family of hormones. American journal of surgery, 183 4, 430-4Balasubramaniam, Ambikaipakan; Sheriff, Sulaiman; Zhai, Weixu; Chance, William T 2002. Bis(31/31')[[Cys(31), Nva(34)]NPY(27-36)-NH(2)]: a neuropeptide Y (NPY) Y(5) receptor selective agonist with a latent stimulatory effect on food intake in rats. Peptides, 23 8, 1485-90Bell, David; Allen, Adrian R; Kelso, Elizabeth J; Balasubramaniam, Ambikaipakan; McDermott, Barbara J 2002. Induction of hypertrophic responsiveness of cardiomyocytes to neuropeptide Y in response to pressure overload. The Journal of pharmacology and experimental therapeutics, 303 2, 581-91Sheriff, Sulaiman; F Qureshy, Asbah; T Chance, William; Kasckow, John W; Balasubramaniam, Ambikaipakan 2002. Predominant role by CaM kinase in NPY Y(1) receptor signaling: involvement of CREB [corrected]. Peptides, 23 1, 87-96Balasubramaniam,A.; Rigel,D.F.; Chance,W.T.; Stein,M.; Fischer,J.E.; King,D.; Plisetskaya,E.M. 1990. Salmon pancreatic polypeptide exhibits neuropeptide y-like activities in rats Peptides, 11 4, 673Balasubramaniam,A.; Sheriff,S. 1990. Neuropeptide y(18-36) is a competitive antagonist of neuropeptide y in rat cardiac ventricular membranes Journal of Biological Chemistry, 265 25, 14724Balasubramaniam,A.; Sheriff,S.; Ferguson,D.G.; Stein,M.; Rigel,D.F. 1990. N-α-biotinylated-neuropeptide y analogs: syntheses, cardiovascular properties, and application to cardiac npy receptor visualization Peptides, 11 6, 1151Balasubramaniam,A.; Sheriff,S.; Renugopalakrishnan,V.; Huang,S.G.; Prabhakaran,M.; Chance,W.T.; Fischer,J.E. 1990. Cardiac properties and conformational studies of neuropeptide y (npy) and npy(17-36) Annals of the New York Academy of Sciences, 611 , 355Balasubramaniam,A.; Sheriff,S.; Rigel,D.F.; Fischer,J.E. 1990. Characterization of neuropeptide y binding sites in rat cardiac ventricular membranes Peptides, 11 3, 545Ramo,O.J.; Balasubramaniam,A.; Sheriff,S.; Rogers,D.H.; McCullough,P.J.; Bell Jr.,R.H. 1990. Neuropeptide y and peptide yy stimulate the growth of exocrine pancreatic carcinoma cells Neuropeptides, 15 2, 101Rudnicki,M.; McFadden,D.W.; Liwnicz,B.H.; Balasubramaniam,A.; Nussbaum,M.S.; Dayal,R.; Fischer,J.E. 1990. Endogenous peptide yy is dependent on jejunal exposure to gastrointestinal contents Journal of Surgical Research, 48 5, 485Sheriff,S.; Rigel,D.F.; Fischer,J.E.; Balasubramaniam,A. 1990. Interaction of 125i-neuropeptide y with rat cardiac membranes Neuropeptides, 15 3, 157Chance,W.T.; Sheriff,S.; Foley-Nelson,T.; Fischer,J.E.; Balasubramaniam,A. 1989. Pertussis toxin inhibits neuropeptide y-induced feeding in rats Peptides, 10 6, 1283Parker S.;Balasubramaniam A. 12-25-2008. Neuropeptide Y Y2 receptor in health and disease (British Journal of Pharmacology (2007) 153, (420-4 British Journal of Pharmacology, 155 8, 1307Balasubramaniam A.;Zhai W.;Tao Z.;Huang Y.;Fischer J.;Eden P.;Taylor J.;Kar L.;Samarasinghe S.;Johnson M. 12-24-1996. Synthesis, structure, and antagonistic properties of Des-Asn<sup>29</sup>[D-Trp-<sup& Peptides, 17 7, 1113-1118Parker M.;Sah R.;Sheriff S.;Balasubramaniam A.;Parker S. 12-15-2005. Internalization of cloned pancreatic polypeptide receptors is accelerated by all types of Y4 agonist Regulatory Peptides, 132 1-3, 91-101Porter J.;Balasubramaniam A.;Abel P.;Conlon J. 12-15-1994. Differential actions of lamprey peptide methionine-tyrosine at Y<inf>1</inf> and Y<in Regulatory Peptides, 54 2-3, 489-493Goumain M.;Voisin T.;Lorinet A.;Balasubramaniam A.;Laburthe M. 12-04-1998. Pharmacological profile of the rat intestinal crypt peptide YY receptor vs. the recombinant rat Y5 r European Journal of Pharmacology, 362 2-3, 245-249Parker M.;Sah R.;Balasubramaniam A.;Sallee F.;Crowley W.;Parker S. 12-01-2013. Neuropeptide y in feeding: Specific and protean actions Neuropeptide Y: Molecular Structure, Role in Food Intake and Direct/Indirect Effects, , 107-167Watanabe M.;Sheriff S.;Ramelot T.;Kadeer N.;Cho J.;Lewis K.;Balasubramaniam A.;Kennedy M. 12-01-2011. NMR based metabonomics study of DAG treatment in a C2C12 mouse skeletal muscle cell line myotube mod International Journal of Peptide Research and Therapeutics, 17 4, 281-299Parker S.;Parker M.;Sallee F.;Balasubramaniam A. 12-01-2007. Oligomerization of neuropeptide Y (NPY) Y2 receptors in CHO cells depends on functional pertussis to Regulatory Peptides, 144 1-3, 72-81Samarasinghe S.;Karl L.;Balasubramaniam A.;Johnson M. 12-01-1997. Sequence-specific <sup>1</sup>H NMR assignments and secondary structure of neuropeptide Protein and Peptide Letters, 4 4, 251-258Millar B.;McDermott B.;Piper H.;Balasubramaniam A.;Weis T. 12-01-1991. NPY-(18-36) and pertussis toxin distinguish between the negative and positive contractile effects of Advances in Experimental Medicine and Biology, 311 , 325-326Millar B.C.;Weis T.;Piper H.M.;Weber M.;Borchard U.;McDermott B.J.;Balasubramaniam A. 12-01-1991. Positive and negative contractile effects of neuropeptide Y on ventricular cardiomyocytes American Journal of Physiology - Heart and Circulatory Physiology, 261 6 30-6, McFadden D.;Rudnicki M.;Nussbaum M.;Balasubramaniam A.;Dayal R.;Fischer J. 12-01-1989. Atropine inhibits the postprandial circulating release of neuropeptide Y in conscious dogs Surgical Forum, 40 , 182-184Murphy R.;Balasubramaniam A.;Mei-Huei Chen;Cardin A.;Rayford P.;Jackson R.;Joffe S. 11-16-1984. Specificity of cholecystokinin antibody may influence choice of tracer for radioimmunoassay Journal of Immunological Methods, 74 1, 199-203Chance W.T.;Foley-Nelson T.;Thomas I.;Balasubramaniam A. 10-13-1997. Prevention of parenteral nutrition-induced gut hypoplasia by coinfusion of glucagon-like peptide-2 American Journal of Physiology - Gastrointestinal and Liver Physiology, 273 2 36-2, Estes A.M.;Wong Y.Y.;Parker M.S.;Sallee F.R.;Balasubramaniam A.;Parker S.L. 10-09-2008. Neuropeptide Y (NPY) Y2 receptors of rabbit kidney cortex are largely dimeric Regulatory Peptides, 150 1-3, 88-94Chance W.T.;Balasubramaniam A.;Thomas I.;Fischer J.E. 10-09-1992. Amylin increases transport of tyrosine and tryptophan into the brain Brain Research, 593 1, 20-24McDermott B.;Millar B.;Dolan F.;Bell D.;Balasubramaniam A. 10-08-1997. Evidence for Y<inf>1</inf> and Y<inf>2</inf> subtypes of neuropeptide Y rece European Journal of Pharmacology, 336 2-3, 257-265Wang B.;Sheriff S.;Balasubramaniam A.;Kennedy M. 10-07-2015. NMR based metabolomics study of Y2 receptor activation by neuropeptide Y in the SK-N-BE2 human neuro Metabolomics, 11 5, 1243-1252McLean L.;Best S.;Balasubramaniam A.;Jackson R. 10-03-1986. Fatty acyl chain specificity of phosphatidylcholine hydrolysis catalyzed by lipoprotein lipase. Effe Biochimica et Biophysica Acta (BBA)/Lipids and Lipid Metabolism, 878 3, 446-449Watanabe M.;Sheriff S.;Kadeer N.;Cho J.;Lewis K.;Balasubramaniam A.;Kennedy M. 10-01-2012. NMR based metabonomics study of NPY Y5 receptor activation in BT-549, a human breast carcinoma cell Metabolomics, 8 5, 854-868Shahab M.;Balasubramaniam A.;Sahu A.;Plant T. 10-01-2003. Central nervous system receptors involved in mediating the inhibitory action of neuropeptide Y on lu Journal of Neuroendocrinology, 15 10, 965-970Balasubramaniam A.;Sheriff S. 09-28-1990. Neuropeptide Y(18-36) is a competitive antagonist of neuropeptide Y in rat cardiac ventricular membr Journal of Biological Chemistry, 265 25, 14724-14727Chance W.;Sheriff S.;Kasckow J.;Regmi A.;Balasubramaniam A. 09-25-1998. NPY messenger RNA is increased in medial hypothalamus of anorectic tumor-bearing rats Regulatory Peptides, 75-76 , 347-353Sheriff S.;Dayal R.;Kasckow J.;Regmi A.;Chance W.;Fischer J.;Balasubramaniam A. 09-25-1998. NPY upregulates genes containing cyclic AMP response element in human neuroblastoma cell lines beari Regulatory Peptides, 75-76 , 309-318Chance W.;Balasubramaniam A.;Borchers M.;Fischer J. 09-11-1995. Refractory hypothalamic adenylate cyclase in anorectic tumor-bearing rats: implications for NPY-indu Brain Research, 691 1-2, 180-184Balasubramaniam A.;Tao Z.;Zhai W.;Stein M.;Sheriff S.;Chance W.;Fischer J.;Eden P.;Taylor J.;Liu C.;McFadden D.;Voisin T.;Roze C.;Laburthe M. 09-07-2000. Structure-activity studies including a ?(CH<inf>2</inf>-NH) scan of peptide YY (PYY) act Journal of Medicinal Chemistry, 43 18, 3420-3427Parker M.;Sah R.;Balasubramaniam A.;Sallee F.;Sweatman T.;Park E.;Parker S. 09-01-2008. Dimers of the neuropeptide Y (NPY) Y2 receptor show asymmetry in agonist affinity and association wi Journal of Receptors and Signal Transduction, 28 5, 437-451Balasubramaniam A. 09-01-2007. Editorial Current Topics in Medicinal Chemistry, 7 17, 1644Diccianni M.B.;Lilly-Stauderman M.;Harmony J.A.K.;McLean L.R.;Balasubramaniam A. 09-01-1991. Heparin Prevents the Binding of Phospholipase A<inf>2</inf> to Phospholipid Micelles: Im Biochemistry, 30 37, 9090-9097Balasubramaniam A.;Renugopalakrishnan V.;Rigel D.;Nussbaum M.;Rapaka R.;Dobbs J.;Carreira L.;Fischer J. 08-31-1989. Synthesis and biological properties of 4-norleucine-neuropeptide Y; secondary structure of neuropept Biochimica et Biophysica Acta (BBA)/Protein Structure and Molecular, 997 3, 176-181Chance W.;Sheriff S.;Moore J.;Peng F.;Balasubramaniam A. 08-24-1998. Reciprocal changes in hypothalamic receptor binding and circulating leptin in anorectic tumor-bearin Brain Research, 803 1-2, 27-33Chance W.;Tao Z.;Sheriff S.;Balasubramaniam A. 08-24-1998. Wryamide, a NPY-based tripeptide that antagonizes feeding in rats Brain Research, 803 1-2, 39-43McLean L.;Balasubramaniam A. 08-21-1992. Promotion of ?-structure by interaction of diabetes associated polypeptide (amylin) with phosphatidy Biochimica et Biophysica Acta (BBA)/Protein Structure and Molecular, 1122 3, 317-320Sheriff S.;Fischer J.;Balasubramaniam A. 08-12-1992. Amylin inhibits insulin-stimulated glucose uptake in C<inf>2</inf>C<inf>12</inf BBA - Molecular Cell Research, 1136 2, 219-222Sheriff S.;Qureshy A.;Chance W.;Kasckow J.;Balasubramaniam A. 07-30-2002. Erratum: Predominant role by CaM kinase in NPY Y<inf>1</inf> receptor signaling: Involve Peptides, 23 6, 1195Amoscato A.;Balasubramaniam A.;Wesley Alexander J.;Bebcock G. 07-20-1988. Degradation of thymopentin by human lymphocytes: evidence for aminopeptidase activity Biochimica et Biophysica Acta (BBA)/Protein Structure and Molecular, 955 2, 164-174Parker S.L.;Parker M.S.;Lundell I.;Balasubramaniam A.;Buschauer A.;Kane J.K.;Yalcin A.;Berglund M.M. 07-15-2002. Agonist internalization by cloned Y1 neuropeptide Y (NPY) receptor in Chinese hamster ovary cells sh Regulatory Peptides, 107 1-3, 49-62James J.H.;Wagner K.R.;King J.K.;Leffler R.E.;Upputuri R.K.;Balasubramaniam A.;Friend L.A.;Shelly D.A.;Paul R.J.;Fischer J.E. 07-01-1999. Stimulation of both aerobic glycolysis and Na<sup>+</sup>-K<sup>+</sup>-ATPa American Journal of Physiology - Endocrinology and Metabolism, 277 1 40-1, Balasubramaniam A.;Rechtin A.;McLean L.;Jackson R.;Demel R. 06-30-1986. Activation of lipoprotein lipase by N-?-palmitoyl (56-79) fragment of apolipoprotein C-II Biochemical and Biophysical Research Communications, 137 3, 1041-1048Balasubramaniam A. 06-09-1997. Neuropeptide Y family of hormones: Receptor subtypes and antagonists Peptides, 18 3, 445-457Chance W.;Balasubramaniam A.;Sheriff S. 06-04-2003. Neuropeptide Y and cancer anorexia Current Medicinal Chemistry - Central Nervous System Agents, 3 2, 127-139Chance W.;Zhang X.;Zuo L.;Balasubramaniam A. 06-01-1998. Reduction of gut hypoplasia and cachexia in tumor-bearing rats maintained on total parenteral nutrit Nutrition, 14 6, 502-507Parker E.;Babij C.;Balasubramaniam A.;Burrier R.;Guzzi M.;Hamud F.;Gitali Mukhopadhyay;Rudinski M.;Tao Z.;Tice M.;Xia L.;Mullins D.;Salisbury B. 05-15-1998. GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y European Journal of Pharmacology, 349 1, 97-105Balasubramaniam A.;Dhawan V.;Mullins D.;Chance W.;Sheriff S.;Guzzi M.;Prabhakaran M.;Parker E. 05-10-2001. Highly selective and potent neuropeptide Y (NPY) Y1 receptor antagonists based on [Pro<sup>30& Journal of Medicinal Chemistry, 44 10, 1479-1482Parker S.L.;Parker M.S.;Estes A.M.;Wong Y.Y.;Sah R.;Sweatman T.;Park E.A.;Balasubramaniam A.;Sallee F.R. 05-01-2008. The neuropeptide Y (NPY) Y2 receptors are largely dimeric in the kidney, but monomeric in the forebr Journal of Receptors and Signal Transduction, 28 3, 245-263Conlon J.M.;Balasubramaniam A.;Hazon N. 05-01-1991. Structural characterization and biological activity of a neuropeptide Y-related peptide from the dog Endocrinology, 128 5, 2273-2279Chance W.;Zhang X.;Balasubramaniam A.;Fischer J. 04-19-1996. Preservation of intestine protein by peptide YY during total parenteral nutrition Life Sciences, 58 21, 1785-1794Chance W.;Balasubramaniam A.;Stallion A.;Fischer J. 04-02-1993. Anorexia following the systemic injection of amylin Brain Research, 607 1-2, 185-188Jois S.;Nagarajarao L.;Prabhakaran M.;Balasubramaniam A. 04-01-2006. Modeling of neuropeptide receptors Y1, Y4, Y5, and docking studies with neuropeptide antagonist anal Journal of Biomolecular Structure and Dynamics, 23 5, 497-508Balasubramaniam A.;Zhai W.;Sheriff S.;Tao Z.;Chance W.;Fischer J.;Eden P.;Taylor J. 03-08-1996. Bis(31/31'){[Cys<sup>31</sup>,Trp<sup>32</sup>,Nva<sup>34</sup>] Journal of Medicinal Chemistry, 39 4, 811-813Parker M.;Balasubramaniam A.;Sallee F.;Parker S. 03-07-2018. The expansion segments of 28S Ribosomal RNA extensively match human messenger RNAs Frontiers in Genetics, 9 MAR, Parker S.;Parker M.;Sah R.;Sallee F.;Balasubramaniam A. 03-01-2007. Parallel inactivation of Y<inf>2</inf> receptor and G-proteins in CHO cells by pertussis Regulatory Peptides, 139 1-3, 128-135Parker E.;Balasubramaniam A.;Guzzi M.;Mullins D.;Salisbury B.;Sheriff S.;Witten M.;Hwa J. 03-01-2000. [D-Trp<sup>34</sup>] neuropeptide Y is a potent and selective neuropeptide Y Y<inf> Peptides, 21 3, 393-399Balasubramaniam A.;Ujhelyi M.;Borchers M.;Huang Y.;Zhai W.;Zhou Y.;Johnson M.;Sheriff S.;Fischer J.E. 03-01-1996. Antagonistic properties of centrally truncated analogs of [D-Trp<sup>32</sup>]NPY Journal of Medicinal Chemistry, 39 5, 1142-1147Balasubramaniam A.;Sheriff S.;Johnson E.;Prabhakaran M.;Huang Y.;Fischer J.;Chance W. 03-01-1994. [d-TRP<sup>32</sup>]Neuropeptide Y: A Competitive Antagonist of NPY in Rat Hypothalamus Journal of Medicinal Chemistry, 37 6, 811-815Michael Conlon J.;Balasubramaniam A.;Sower S. 02-24-1994. Purification of a neuropeptide Y-related peptide from the brain of the sea lamprey and its effect on Regulatory Peptides, 50 2, 167-175Jackson R.;Balasubramaniam A.;Murphy R.;Demel R. 02-12-1986. Interaction of synthetic peptides of apolipoprotein C-II and lipoprotein lipase at monomolecular lip Biochimica et Biophysica Acta (BBA)/Lipids and Lipid Metabolism, 875 2, 203-210Parker M.;Sah R.;Balasubramaniam A.;Sallee F.;Zerbe O.;Parker S. 02-01-2011. Non-specific binding and general cross-reactivity of y receptor agonists are correlated and should i Peptides, 32 2, 258-265Parker S.;Parker M.;Sah R.;Balasubramaniam A.;Sallee F. 02-01-2007. Self-regulation of agonist activity at the Y receptors Peptides, 28 2, 203-213Sheriff S.;Chance W.T.;Iqbal S.;Rizvi T.A.;Xiao C.;Kasckow J.W.;Balasubramaniam A. 02-01-2003. Hypothalamic administration of cAMP agonist/PKA activator inhibits both schedule feeding and NPY-ind Peptides, 24 2, 245-254Chance W.T.;Balasubramaniam A.;Zhang F.S.;Wimalawansa S.J.;Fischer J.E. 01-25-1991. Anorexia following the intrahypothalamic administration of amylin Brain Research, 539 2, 352-354Gangadhar B.P.;Jois S.D.S.;Balasubramaniam A. 01-05-2004. Convenient high yield and stereoselective synthesis of O-glycopeptides using N-?-Fmoc-Tyr/Ser[?-D-Gl Tetrahedron Letters, 45 2, 355-358Parker M.;Sah R.;Park E.;Sweatman T.;Balasubramaniam A.;Sallee F.;Parker S. 01-01-2009. Oligomerization of the heptahelical G protein coupling receptors: A case for association using trans Mini-Reviews in Medicinal Chemistry, 9 3, 329-339Parker S.;Balasubramaniam A. 01-01-2008. Neuropeptide Y Y2 receptor in health and disease British Journal of Pharmacology, 153 3, 420-431Jois S.;Nagarajarao L.;Prabhakaran M.;Balasubramaniam A. 01-01-2004. Modeling of neuropeptide receptors y1, y4, y5, and docking studies with neuropeptide antagonist anal Journal of Biomolecular Structure and Dynamics, 22 1, 497-508Goumain M.;Voisin T.;Lorinet A.;Ducroc R.;Tsocas A.;Rozé C.;Rouet-Benzineb P.;Herzog H.;Balasubramaniam A.;Laburthe M. 01-01-2001. The peptide YY-preferring receptor mediating inhibition of small intestinal secretion is a periphera Molecular Pharmacology, 60 1, 124-134Sheriff S.;Dautzenberg F.;Mulchahey J.;Pisarska M.;Hauger R.;Chance W.;Balasubramaniam A.;Kasckow J. 01-01-2001. Interaction of neuropeptide Y and corticotropin-releasing factor signaling pathways in AR-5 amygdala Peptides, 22 12, 2083-2089Chance W.;Sheriff S.;Peng F.;Balasubramaniam A. 01-01-2000. Antagonism of NPY-induced feeding by pretreatrnent with cyclic AMP response element binding protein Neuropeptides, 34 3-4, 167-172Chance W.T.;Sheriff S.;Foley-Nelson T.;Thomas I.;Balasubramaniam A. 01-01-2000. Maintaining gut integrity during parenteral nutrition of tumor-bearing rats: Effects of glucagon-lik Nutrition and Cancer, 37 2, 215-222Sheriff S.;Chance W.T.;Balasubramaniam A. 01-01-2000. Antisense oligonucleotide approach to study NPY-mediated feeding signal transduction. Methods in molecular biology (Clifton, N.J.), 153 , 103-114Litvak D.;Iseki H.;Evers B.;Greeley G.;Hellmich M.;Iwase K.;Balasubramaniam A.;Townsend C. 01-01-1999. Characterization of two novel proabsorptive peptide YY analogs, BIM- 43073D and BIM-43004C Digestive Diseases and Sciences, 44 3, 643-648Mulchahey J.;Regmi A.;Sheriff S.;Balasubramaniam A.;Kasckow J. 01-01-1999. Coordinate and divergent regulation of corticotropin-releasing factor (CRF) and CRF-binding protein Endocrinology, 140 1, 251-259Samarasinghe S.;Balasubramaniam A.;Johnson M. 01-01-1997. Proton nuclear magnetic resonance studies of the structure of neuropeptide Y and its analogs Current Medicinal Chemistry, 4 2, 151-158Sheriff S.;Chance W.;Fischer J.;Balasubramaniam A. 01-01-1997. Neuropeptide Y treatment and food deprivation increase cyclic AMP response element-binding in rat hy Molecular Pharmacology, 51 4, 597-604Souli A.;Chariot J.;Voisin T.;Presset O.;Tsocas A.;Balasubramaniam A.;Laburthe M.;Rozé C. 01-01-1997. Several receptors mediate the antisecretory effect of peptide YY, neuropeptide Y, and pancreatic pol Peptides, 18 4, 551-557Chance W.;Balasubramaniam A.;Thompson H.;Mohapatra B.;Ramo J.;Fischer J. 01-01-1996. Assessment of feeding response of tumor-bearing rats to hypothalamic injection and infusion of neuro Peptides, 17 5, 797-801Huang Y.;Fischer J.E.;Balasubramaniam A. 01-01-1996. Amylin mobilizes [Ca<sup>2+</sup>]<inf>i</inf> and stimulates the release of Peptides, 17 3, 497-502Liu C.;Rongione A.;Garvey L.;Balasubramaniam A.;McFadden D. 01-01-1996. Adjuvant hormonal treatment with peptide YY or its analog decreases human pancreatic carcinoma growt American Journal of Surgery, 171 1, 192-196Chance W.;Balasubramaniam A.;Fischer J. 01-01-1995. Neuropeptide Y and the development of cancer anorexia Annals of Surgery, 221 5, 579-589Clay M.;Anantharamaiah M.;Mistry M.;Balasubramaniam A.;Harmony J. 01-01-1995. Localization of a Domain in Apolipoprotein E with both Cytostatic and Cytotoxic Activity Biochemistry, 34 35, 11142-11151Eto B.;Boisset M.;Eden P.;Balasubramaniam A.;Desjeux J. 01-01-1995. Effects of peptide YY and its analogues on chloride ion secretion in fed and fasted rat jejunum Peptides, 16 8, 1403-1409Liu C.;Balasubramaniam A.;Saxton R.;Paiva M.;McFadden D. 01-01-1995. Human pancreatic cancer growth is inhibited by peptide YY and BIM-43004-1 Journal of Surgical Research, 58 6, 707-712Liu C.;Slice L.;Balasubramaniam A.;Walsh J.;Newton T.;Saxton R.;McFadden D. 01-01-1995. Y2 receptors decrease human pancreatic cancer growth and intracellular cyclic adenosine monophosphat Surgery, 118 2, 229-236Lui C.;Hines O.;Whang E.;Balasubramaniam A.;Newton T.;Zinner M.;Ashley S.;McFadden D. 01-01-1995. A novel synthetic analog of peptide YY, BIM-43004, given intraluminally, is proabsorptive Journal of Surgical Research, 59 1, 80-84Chance W.;Balasubramaniam A.;Dayal R.;Brown J.;Fischer J. 01-01-1994. Hypothalamic concentration and release of neuropeptide Y into microdialysates is reduced in anorecti Life Sciences, 54 24, 1869-1874Chance W.T.;Balasubramaniam A.;Sheriff S.;Fischer J.E. 01-01-1994. Possible role of neuropeptide Y in experimental cancer anorexia Advances in Experimental Medicine and Biology, 354 , 185-201Balasubramaniam A.;Cox H.;Voisin T.;Laburthe M.;Stein M.;Fischer J. 01-01-1993. Structure-activity studies of peptide YY(22-36): N-?-Ac-[Phe<sup>27</sup>]PYY(22-36), a Peptides, 14 5, 1011-1016Bjenning C.;Hazon N.;Balasubramaniam A.;Holmgren S.;Conlon J.M. 01-01-1993. Distribution and activity of dogfish NPY and peptide YY in the cardiovascular system of the common d American Journal of Physiology - Regulatory Integrative and Comparative Physiology, 264 6 33-6, Lilly-Stauderman M.;Brown T.;Balasubramaniam A.;Harmony J. 01-01-1993. Heparin releases newly synthesized cell surface-associated apolipoprotein E from HepG2 cells Journal of Lipid Research, 34 2, 190-200Wadhwa S.;Jotwani G.;Balasubramaniam A. 01-01-1993. Development of neuropeptide Y-like immunoreactivity in the rat heart Acta Histochemica et Cytochemica, 26 3, 227-232Balasubramaniam A.;Rigel D.;Chance W.;Fischer J. 01-01-1992. Central and peripheral effects of sculpin pancreatic polypeptide and anglerfish peptide Y in rats. Peptide research, 5 2, 106-109Chance W.;Balasubramaniam A.;Chen X.;Fischer J. 01-01-1992. Tests of adipsia and conditioned taste aversion following the intrahypothalamic injection of amylin Peptides, 13 5, 961-964Inui A.;Okita M.;Miura M.;Hirosue Y.;Nakajima M.;Shii K.;Baba S.;Balasubramaniam A.;Kasuga M. 01-01-1992. Solubilization of high affinity peptide-YY receptors from porcine brain Endocrinology, 130 4, 2120-2128Sheriff S.;Balasubramaniam A. 01-01-1992. Inhibitory and stimulatory effects of neuropeptide Y(17-36) on rat cardiac adenylate cyclase activit Journal of Biological Chemistry, 267 7, 4680-4685Sheriff S.;Fischer J.;Balasubramaniam A. 01-01-1992. Characterization of amylin binding sites in a human hepatoblastoma cell line Peptides, 13 6, 1193-1199Balasubramaniam A.;Renugopalakrishnan V.;Stein M.;Fischer J.;Chance W. 01-01-1991. Syntheses, structures and anorectic effects of human and rat amylin Peptides, 12 5, 919-924Mcfadden D.;Rudnicki M.;Balasubramaniam A.;Fischer J. 01-01-1991. Intraluminal Heal Recovery of Pancreatic Polypeptide Archives of Surgery, 126 8, 1032-1035Balasubramaniam A.;Rigel D.F.;Chance W.T.;Stein M.;Fischer J.E.;King D.;Plisetskaya E.M. 01-01-1990. Salmon pancreatic polypeptide exhibits neuropeptide Y-like activities in rats Peptides, 11 4, 673-677Balasubramaniam A.;Sheriff S.;Ferguson D.G.;Stein M.;Rigel D.F. 01-01-1990. N-?-biotinylated-neuropeptide Y analogs: Syntheses, cardiovascular properties, and application to ca Peptides, 11 6, 1151-1156BALASUBRAMANIAM A.;SHERIFF S.;RENUGOPALAKRISHNAN V.;HUANG S.;PRABHAKARAN M.;CHANCE W.;FISCHER J. 01-01-1990. Cardiac Properties and Conformational Studies of Neuropeptide Y (NPY) and NPY(17–36) Annals of the New York Academy of Sciences, 611 1, 355-358Balasubramaniam A.;Sheriff S.;Rigel D.F.;Fischer J.E. 01-01-1990. Characterization of neuropeptide Y binding sites in rat cardiac ventricular membranes Peptides, 11 3, 545-550CHANCE W.T.;RAMO J.;SHERIFF S.;ZHANG F.;FISCHER J.E.;BALASUBRAMANIAM A. 01-01-1990. Reduction of Neuropeptide Y?Induced Feeding in Tumor?Bearing Rats Annals of the New York Academy of Sciences, 611 1, 497-499Rämö O.;Balasubramaniam A.;Sheriff S.;Rogers D.;McCullough P.;Bell R. 01-01-1990. Neuropeptide Y and peptide YY stimulate the growth of exocrine pancreatic carcinoma cells Neuropeptides, 15 2, 101-106Rudnicki M.;McFadden D.;Balasubramaniam A.;Nussbaum M.;Fischer J. 01-01-1990. The postprandial circulatory and lleal intraluminal release of neuropeptide Y in conscious dogs Journal of Surgical Research, 49 6, 514-518RUDNICKI M.;McFADDEN D.;BALASUBRAMANIAM A.;NUSSBAUM M.;FISCHER J. 01-01-1990. Neuropeptide Y and Anglerfish Peptide Amide Inhibit Secretin?Stimulated Pancreatic Exocrine Secretio Annals of the New York Academy of Sciences, 611 1, 423-425Rudnicki M.;McFadden D.;Liwnicz B.;Balasubramaniam A.;Nussbaum M.;Dayal R.;Fischer J. 01-01-1990. Endogenous peptide YY is dependent on jejunal exposure to gastrointestinal contents Journal of Surgical Research, 48 5, 485-490Rudnicki M.;Patel D.G.;McFadden D.W.;Balasubramaniam A.;Nussbaum M.S.;Fischer J.E. 01-01-1990. Proximal jejunal and biliary effects on the enteroinsular axis Surgery, 107 4, 455-460Sheriff S.;Rigel D.;Fischer J.;Balasubramaniam A. 01-01-1990. Interaction of <sup>125</sup>I-Neuropeptide Y with rat cardiac membranes Neuropeptides, 15 3, 157-160Balasubramaniam A.;Andrews P.C.;Renugopalakrishnan V.;Rigel D.F. 01-01-1989. Glycine-extended anglerfish peptide YG (aPY) a neuropeptide Y (NPY) homologue may be a precursor of Peptides, 10 3, 581-585BALASUBRAMANIAM A.;KNITTEL J.J.;GILL C.;ANDREWS P.C. 01-01-1989. Detection of conformational isomers of anglerfish peptide YG (aPY) by reversed phase chromatography International Journal of Peptide and Protein Research, 34 2, 158-160Balasubramaniam A.;McFadden D.;Rudnicki M.;Nussbaum M.;Dayal R.;Srivastava L.;Fischer J. 01-01-1989. Radioimmunoassay to determine postprandial changes in plasma Neuropeptide Y levels in awake dogs Neuropeptides, 14 3, 209-212Chance W.T.;Sheriff S.;Foley-Nelson T.;Fischer J.E.;Balasubramaniam A. 01-01-1989. Pertussis toxin inhibits neuropeptide Y-induced feeding in rats Peptides, 10 6, 1283-1286McFadden D.;Rudnicki M.;Nussbaum M.;Balasubramaniam A.;Fischer J. 01-01-1989. Independent release of peptide YY (PYY) into the circulation and ileal lumen of the awake dog Journal of Surgical Research, 46 4, 380-385Milgram S.;Balasubramaniam A.;Andrews P.;McDonald J.;Noe B. 01-01-1989. Characterization of aPY-like peptides in anglerfish brain using a novel radioimmunoassay for aPY-Gly Peptides, 10 5, 1013-1017Noe B.;Milgram S.;Balasubramaniam A.;Andrews P.;Calka J.;McDonald J. 01-01-1989. Localization and characterization of neuropeptide Y-like peptides in the brain and islet organ of th Cell and Tissue Research, 257 2, 303-311Renugopalakrishnan V.;Prabhakaran M.;Huang S.;Balasubramaniam A.;Strawich E.;Glimcher M. 01-01-1989. Secondary structure and limited three-dimensional structure of bovine amelogenin Connective Tissue Research, 22 1-4, 757-764Rigel D.;Grupp I.;Balasubramaniam A.;Grupp G. 01-01-1989. Contractile effects of cardiac neuropeptides in isolated canine atrial and ventricular muscles American Journal of Physiology - Heart and Circulatory Physiology, 257 4, Servin A.L.;Rouyer-Fessard C.;Balasubramaniam A.;Pierre S.S.;Laburthe M. 01-01-1989. Peptide-yy and neuropeptide-y inhibit vasoactive intestinal peptide-stimulated adenosine 3', 5'-mono Endocrinology, 124 2, 692-700Balasubramaniam A.;Grupp I.;Matlib M.;Benza R.;Jackson R.;Fischer J.;Grupp G. 01-01-1988. Comparison of the effects of neuropeptide Y (NPY) and 4-norleucine-NPY on isolated perfused rat hear Regulatory Peptides, 21 3-4, 289-299Balasubramaniam A.;Servin A.L.;Rigel D.F.;Rouyer-Fessard C.R.;Laburthe M. 01-01-1988. Syntheses and receptor affinities of partial sequences of peptide YY (PYY). Peptide research, 1 1, 32-35McFadden D.;Nussbaum M.;Rudnicki M.;Balasubramaniam A.;Fischer J. 01-01-1988. Postprandial neuropeptide Y release in the conscious dog Surgical Forum, 39 , 143-145Balasubramaniam A.;Chopra Y.;Yates M.;Jackson R. 01-01-1987. Total synthesis of human plasma apolipoprotein C-II Bioorganic Chemistry, 15 2, 141-151BALASUBRAMANIAM A.;GRUPP I.;SRIVASTAVA L.;TATEMOTO K.;MURPHY R.F.;JOFFE S.N.;FISCHER J.E. 01-01-1987. Synthesis of neuropeptide Y International Journal of Peptide and Protein Research, 29 1, 78-83Clark J.;Sahu A.;Kalra P.;Balasubramaniam A.;Kalra S. 01-01-1987. Neuropeptide Y (NPY)-induced feeding behavior in female rats: comparison with human NPY ([Met<sup Regulatory Peptides, 17 1, 31-39Sahu A.;Crowley W.;Tatemoto K.;Balasubramaniam A.;Kalra S. 01-01-1987. Effects of neuropeptide Y, NPY analog (norleucine<sup>4</sup>-NPY), galanin and neuropep Peptides, 8 5, 921-926Balasubramaniam A.;Demel R.;Murphy R.;Sparrow J.;Jackson R. 01-01-1986. Substitution of SER<inf>61</inf> ? GLY<inf>61</inf> in human apolipoprotein Chemistry and Physics of Lipids, 39 4, 341-346BALASUBRAMANIAM A.;MURPHY R.;BLUMENTHAL K. 01-01-1986. Synthesis of sequences 1–16 and 63–95 of Cerebratulus lacteus toxin AIII: Hemolytic activity in a to International Journal of Peptide and Protein Research, 27 5, 508-513
Balasubramaniam, Ambikaipakan; Sheriff, Sulaiman; Friend, Lou Ann; James, J Howard 2018. Phosphodiesterase (PDE) 4B Knock-out Prevents Skeletal Muscle Atrophy in Rats with Burn Injury. American journal of physiology. Regulatory, integrative and comparative physiology, , Parker, Michael S; Balasubramaniam, Ambikaipakan; Parker, Steven L 2018. The Expansion Segments of Human 28S rRNA Match MicroRNAs Much Above 18S rRNA or Core Segments. MicroRNA (Shariqah, United Arab Emirates), 7 2, 128-137Parker, Michael S; Balasubramaniam, Ambikaipakan; Sallee, Floyd R; Parker, Steven L 2018. The Expansion Segments of 28S Ribosomal RNA Extensively Match Human Messenger RNAs. Frontiers in genetics, 9 , 66Parker, Michael S; Balasubramaniam, Ambikaipakan; Sallee, Floyd R; Parker, Steven L 2017. Canonical microRNA matching differs greatly across groups of G-protein coupled receptor mRNAs. MicroRNA (Shariqah, United Arab Emirates), , Portelli, Jeanelle; Meurs, Alfred; Bihel, Frederic; Hammoud, Hassan; Schmitt, Martine; De Kock, Joery; Utard, Valerie; Humbert, Jean-Paul; Bertin, Isabelle; Buffel, Ine; Coppens, Jessica; Tourwe, Dirk; Maes, Veronique; De Prins, An; Vanhaecke, Tamara; Massie, Ann; Balasubramaniam, Ambikaipakan; Boon, Paul; Bourguignon, Jean-Jacques; Simonin, Frederic; Smolders, Ilse 2015. Neuropeptide FF receptors as novel targets for limbic seizure attenuation. Neuropharmacology, 95 , 415-23Joshi, Rashika; Kadeer, Nijiati; Sheriff, Sulaiman; Friend, Lou Ann; James, J Howard; Balasubramaniam, Ambikaipakan 2014. Phosphodiesterase (PDE) inhibitor torbafylline (HWA 448) attenuates burn-induced rat skeletal muscle proteolysis through the PDE4/cAMP/EPAC/PI3K/Akt pathway. Molecular and cellular endocrinology, 393 1-2, 152-63Parker, Michael S; Sah, Renu; Balasubramaniam, Ambikaipakan; Park, Edwards A; Sallee, Floyd R; Parker, Steven L 2014. Dimers of G-protein coupled receptors as versatile storage and response units. International journal of molecular sciences, 15 3, 4856-77Parker, Michael S; Sah, Renu; Balasubramaniam, Ambikaipakan; Sallee, Floyd R; Park, Edwards A; Parker, Steven L 2014. On the expansion of ribosomal proteins and RNAs in eukaryotes. Amino acids, 46 7, 1589-604Sheriff, Sulaiman; Kadeer, Nijiati; Friend, Lou Ann; James, J Howard; Alexander, J Wesley; Balasubramaniam, Ambikaipakan 2014. Des-acyl-ghrelin (DAG) normalizes hyperlactacidemia and improves survival in a lethal rat model of burn trauma. Peptides, 60 , 1-7Meurs, Alfred; Portelli, Jeanelle; Clinckers, Ralph; Balasubramaniam, Ambikaipakan; Michotte, Yvette; Smolders, Ilse 2012. Neuropeptide Y increases in vivo hippocampal extracellular glutamate levels through Y1 receptor activation. Neuroscience letters, 510 2, 143-7Parker, Michael S; Balasubramaniam, Ambikaipakan; Parker, Steven L 2012. On the segregation of protein ionic residues by charge type. Amino acids, 43 6, 2231-47Sheriff, Sulaiman; Kadeer, Nijiati; Joshi, Rashika; Friend, Lou Ann; James, J Howard; Balasubramaniam, Ambikaipakan 2012. Des-acyl ghrelin exhibits pro-anabolic and anti-catabolic effects on C2C12 myotubes exposed to cytokines and reduces burn-induced muscle proteolysis in rats. Molecular and cellular endocrinology, 351 2, 286-95Watanabe, Miki; Sheriff, Sulaiman; Lewis, Kenneth B; Cho, Junho; Tinch, Stuart L; Balasubramaniam, Ambikaipakan; Kennedy, Michael A 2012. Metabolic Profiling Comparison of Human Pancreatic Ductal Epithelial Cells and Three Pancreatic Cancer Cell Lines using NMR Based Metabonomics. Journal of molecular biomarkers & diagnosis, 3 2, Watanabe, Miki; Sheriff, Sulaiman; Lewis, Kenneth B; Tinch, Stuart L; Cho, Junho; Balasubramaniam, Ambikaipakan; Kennedy, Michael A 2012. HMGA-targeted phosphorothioate DNA aptamers increase sensitivity to gemcitabine chemotherapy in human pancreatic cancer cell lines. Cancer letters, 315 1, 18-27Estes, Anne-Marie; McAllen, Kathleen; Parker, Michael S; Sah, Renu; Sweatman, Trevor; Park, Edwards A; Balasubramaniam, Ambikaipakan; Sallee, Floyd R; Walker, Mary W; Parker, Steven L 2011. Maintenance of Y receptor dimers in epithelial cells depends on interaction with G-protein heterotrimers. Amino acids, 40 2, 371-80Li, Jiang-Bo; Asakawa, Akihiro; Terashi, Mutsumi; Cheng, KaiChun; Chaolu, Huhe; Zoshiki, Takahiro; Ushikai, Miharu; Sheriff, Sulaiman; Balasubramaniam, Ambikaipakan; Inui, Akio 2010. Regulatory effects of Y4 receptor agonist (BVD-74D) on food intake. Peptides, 31 9, 1706-10Sheriff, Sulaiman; Ali, Marwan; Yahya, Ayesha; Haider, Khawaja H; Balasubramaniam, Ambikaipakan; Amlal, Hassane 2010. Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line. Molecular cancer research : MCR, 8 4, 604-14Wang, Yigang; Zhang, Dongsheng; Ashraf, Muhammad; Zhao, Tiemin; Huang, Wei; Ashraf, Atif; Balasubramaniam, Ambikaipakan 2010. Combining neuropeptide Y and mesenchymal stem cells reverses remodeling after myocardial infarction. American journal of physiology. Heart and circulatory physiology, 298 1, H275-86Balasubramaniam, Ambikaipakan; Joshi, Rashika; Friend, Lou Ann; James, J Howard 2009. GHRP-2 attenuates burn-induced dysfunctions in rodents. Advances in experimental medicine and biology, 611 , 571-2Balasubramaniam, Ambikaipakan; Joshi, Rashika; Su, Chunhua; Friend, Lou Ann; Sheriff, Sulaiman; Kagan, Richard J; James, J Howard 2009. Ghrelin inhibits skeletal muscle protein breakdown in rats with thermal injury through normalizing elevated expression of E3 ubiquitin ligases MuRF1 and MAFbx. American journal of physiology. Regulatory, integrative and comparative physiology, 296 4, R893-901Sheriff, Sulaiman; Joshi, Rashika; Friend, Lou Ann; James, J Howard; Balasubramaniam, Ambikaipakan 2009. Ghrelin receptor agonist, GHRP-2, attenuates burn injury-induced MuRF-1 and MAFbx expression and muscle proteolysis in rats. Peptides, 30 10, 1909-13Parker, Steven L; Parker, Michael S; Sah, Renu; Balasubramaniam, Ambikaipakan; Sallee, Floyd R 2008. Pertussis toxin induces parallel loss of neuropeptide Y Y1 receptor dimers and Gi alpha subunit function in CHO cells. European journal of pharmacology, 579 1-3, 13-25Parker, Steven L; Parker, Michael S; Wong, Ying Y; Sah, Renu; Balasubramaniam, Ambikaipakan; Sallee, Floyd 2008. Importance of a N-terminal aspartate in the internalization of the neuropeptide Y Y2 receptor. European journal of pharmacology, 594 1-3, 26-31Balasubramaniam, Ambikaipakan; Joshi, Rashika; Su, Chunhua; Friend, Lou Ann; James, J Howard 2007. Neuropeptide Y (NPY) Y2 receptor-selective agonist inhibits food intake and promotes fat metabolism in mice: combined anorectic effects of Y2 and Y4 receptor-selective agonists. Peptides, 28 2, 235-40Sah, Renu; Parker, Steven L; Sheriff, Sulaiman; Eaton, Katherine; Balasubramaniam, Ambikaipakan; Sallee, Floyd R 2007. Interaction of NPY compounds with the rat glucocorticoid-induced receptor (GIR) reveals similarity to the NPY-Y2 receptor. Peptides, 28 2, 302-9Amlal, Hassane; Faroqui, Somia; Balasubramaniam, Ambikaipakan; Sheriff, Sulaiman 2006. Estrogen up-regulates neuropeptide Y Y1 receptor expression in a human breast cancer cell line. Cancer research, 66 7, 3706-14Balasubramaniam, Ambikaipakan; Mullins, Deborra E; Lin, Shu; Zhai, Wexiu; Tao, Zhiyong; Dhawan, Vikas C; Guzzi, Mario; Knittel, James J; Slack, Katy; Herzog, Herbert; Parker, Eric M 2006. Neuropeptide Y (NPY) Y4 receptor selective agonists based on NPY(32-36): development of an anorectic Y4 receptor selective agonist with picomolar affinity. Journal of medicinal chemistry, 49 8, 2661-5Balasubramaniam, Ambikaipakan; Wood, Steve; Joshi, Rashika; Su, Chunhua; Friend, Lou Ann; Sheriff, Sulaiman; James, J Howard 2006. Ghrelin stimulates food intake and growth hormone release in rats with thermal injury: synthesis of ghrelin. Peptides, 27 7, 1624-31Chance, William T; Sheriff, Sulaiman; Dayal, Ramesh; Friend, Lou Ann; Thomas, Ingrid; Balasubramaniam, Ambikaipakan 2006. The role of polyamines in glucagon-like peptide-2 prevention of TPN-induced gut hypoplasia. Peptides, 27 4, 883-92Parker, Michael S; Sah, Renu; Balasubramaniam, Ambikaipakan; Parker, Steven L 2005. Lithium inhibits internalization and endosomal processing of both neuropeptide Y (NPY) Y1 and transferrin receptors. Neuroscience letters, 374 1, 43-6Sah, Renu; Balasubramaniam, Ambikaipakan; Parker, Michael S; Sallee, Floyd; Parker, Steven L 2005. Neuropeptide Y as a partial agonist of the Y1 receptor. European journal of pharmacology, 525 1-3, 60-8Balasubramaniam, Ambikaipakan 2003. Neuropeptide Y (NPY) family of hormones: progress in the development of receptor selective agonists and antagonists. Current pharmaceutical design, 9 15, 1165-75Chance, William T; Sheriff, Sulaiman; Dayal, Rameshewar; Balasubramaniam, Ambikaipakan 2003. Refractory hypothalamic alpha-mSH satiety and AGRP feeding systems in rats bearing MCA sarcomas. Peptides, 24 12, 1909-19Jois, Seetharama D S; Balasubramaniam, Ambikaipakan 2003. Conformation of neuropeptide Y receptor antagonists: structural implications in receptor selectivity. Peptides, 24 7, 1035-43Parker, Steven L; Parker, Michael S; Buschauer, Armin; Balasubramaniam, Ambikaipakan 2003. Ligand internalization by cloned neuropeptide Y Y5 receptors excludes Y2 and Y4 receptor-selective peptides. European journal of pharmacology, 474 1, 31-42Balasubramaniam, Ambikaipakan 2002. Clinical potentials of neuropeptide Y family of hormones. American journal of surgery, 183 4, 430-4Balasubramaniam, Ambikaipakan; Sheriff, Sulaiman; Zhai, Weixu; Chance, William T 2002. Bis(31/31')[[Cys(31), Nva(34)]NPY(27-36)-NH(2)]: a neuropeptide Y (NPY) Y(5) receptor selective agonist with a latent stimulatory effect on food intake in rats. Peptides, 23 8, 1485-90Bell, David; Allen, Adrian R; Kelso, Elizabeth J; Balasubramaniam, Ambikaipakan; McDermott, Barbara J 2002. Induction of hypertrophic responsiveness of cardiomyocytes to neuropeptide Y in response to pressure overload. The Journal of pharmacology and experimental therapeutics, 303 2, 581-91Sheriff, Sulaiman; F Qureshy, Asbah; T Chance, William; Kasckow, John W; Balasubramaniam, Ambikaipakan 2002. Predominant role by CaM kinase in NPY Y(1) receptor signaling: involvement of CREB [corrected]. Peptides, 23 1, 87-96Balasubramaniam,A.; Rigel,D.F.; Chance,W.T.; Stein,M.; Fischer,J.E.; King,D.; Plisetskaya,E.M. 1990. Salmon pancreatic polypeptide exhibits neuropeptide y-like activities in rats Peptides, 11 4, 673Balasubramaniam,A.; Sheriff,S. 1990. Neuropeptide y(18-36) is a competitive antagonist of neuropeptide y in rat cardiac ventricular membranes Journal of Biological Chemistry, 265 25, 14724Balasubramaniam,A.; Sheriff,S.; Ferguson,D.G.; Stein,M.; Rigel,D.F. 1990. N-α-biotinylated-neuropeptide y analogs: syntheses, cardiovascular properties, and application to cardiac npy receptor visualization Peptides, 11 6, 1151Balasubramaniam,A.; Sheriff,S.; Renugopalakrishnan,V.; Huang,S.G.; Prabhakaran,M.; Chance,W.T.; Fischer,J.E. 1990. Cardiac properties and conformational studies of neuropeptide y (npy) and npy(17-36) Annals of the New York Academy of Sciences, 611 , 355Balasubramaniam,A.; Sheriff,S.; Rigel,D.F.; Fischer,J.E. 1990. Characterization of neuropeptide y binding sites in rat cardiac ventricular membranes Peptides, 11 3, 545Ramo,O.J.; Balasubramaniam,A.; Sheriff,S.; Rogers,D.H.; McCullough,P.J.; Bell Jr.,R.H. 1990. Neuropeptide y and peptide yy stimulate the growth of exocrine pancreatic carcinoma cells Neuropeptides, 15 2, 101Rudnicki,M.; McFadden,D.W.; Liwnicz,B.H.; Balasubramaniam,A.; Nussbaum,M.S.; Dayal,R.; Fischer,J.E. 1990. Endogenous peptide yy is dependent on jejunal exposure to gastrointestinal contents Journal of Surgical Research, 48 5, 485Sheriff,S.; Rigel,D.F.; Fischer,J.E.; Balasubramaniam,A. 1990. Interaction of 125i-neuropeptide y with rat cardiac membranes Neuropeptides, 15 3, 157Chance,W.T.; Sheriff,S.; Foley-Nelson,T.; Fischer,J.E.; Balasubramaniam,A. 1989. Pertussis toxin inhibits neuropeptide y-induced feeding in rats Peptides, 10 6, 1283Parker S.;Balasubramaniam A. 12-25-2008. Neuropeptide Y Y2 receptor in health and disease (British Journal of Pharmacology (2007) 153, (420-4 British Journal of Pharmacology, 155 8, 1307Balasubramaniam A.;Zhai W.;Tao Z.;Huang Y.;Fischer J.;Eden P.;Taylor J.;Kar L.;Samarasinghe S.;Johnson M. 12-24-1996. Synthesis, structure, and antagonistic properties of Des-Asn<sup>29</sup>[D-Trp-<sup& Peptides, 17 7, 1113-1118Parker M.;Sah R.;Sheriff S.;Balasubramaniam A.;Parker S. 12-15-2005. Internalization of cloned pancreatic polypeptide receptors is accelerated by all types of Y4 agonist Regulatory Peptides, 132 1-3, 91-101Porter J.;Balasubramaniam A.;Abel P.;Conlon J. 12-15-1994. Differential actions of lamprey peptide methionine-tyrosine at Y<inf>1</inf> and Y<in Regulatory Peptides, 54 2-3, 489-493Goumain M.;Voisin T.;Lorinet A.;Balasubramaniam A.;Laburthe M. 12-04-1998. Pharmacological profile of the rat intestinal crypt peptide YY receptor vs. the recombinant rat Y5 r European Journal of Pharmacology, 362 2-3, 245-249Parker M.;Sah R.;Balasubramaniam A.;Sallee F.;Crowley W.;Parker S. 12-01-2013. Neuropeptide y in feeding: Specific and protean actions Neuropeptide Y: Molecular Structure, Role in Food Intake and Direct/Indirect Effects, , 107-167Watanabe M.;Sheriff S.;Ramelot T.;Kadeer N.;Cho J.;Lewis K.;Balasubramaniam A.;Kennedy M. 12-01-2011. NMR based metabonomics study of DAG treatment in a C2C12 mouse skeletal muscle cell line myotube mod International Journal of Peptide Research and Therapeutics, 17 4, 281-299Parker S.;Parker M.;Sallee F.;Balasubramaniam A. 12-01-2007. Oligomerization of neuropeptide Y (NPY) Y2 receptors in CHO cells depends on functional pertussis to Regulatory Peptides, 144 1-3, 72-81Samarasinghe S.;Karl L.;Balasubramaniam A.;Johnson M. 12-01-1997. Sequence-specific <sup>1</sup>H NMR assignments and secondary structure of neuropeptide Protein and Peptide Letters, 4 4, 251-258Millar B.;McDermott B.;Piper H.;Balasubramaniam A.;Weis T. 12-01-1991. NPY-(18-36) and pertussis toxin distinguish between the negative and positive contractile effects of Advances in Experimental Medicine and Biology, 311 , 325-326Millar B.C.;Weis T.;Piper H.M.;Weber M.;Borchard U.;McDermott B.J.;Balasubramaniam A. 12-01-1991. Positive and negative contractile effects of neuropeptide Y on ventricular cardiomyocytes American Journal of Physiology - Heart and Circulatory Physiology, 261 6 30-6, McFadden D.;Rudnicki M.;Nussbaum M.;Balasubramaniam A.;Dayal R.;Fischer J. 12-01-1989. Atropine inhibits the postprandial circulating release of neuropeptide Y in conscious dogs Surgical Forum, 40 , 182-184Murphy R.;Balasubramaniam A.;Mei-Huei Chen;Cardin A.;Rayford P.;Jackson R.;Joffe S. 11-16-1984. Specificity of cholecystokinin antibody may influence choice of tracer for radioimmunoassay Journal of Immunological Methods, 74 1, 199-203Chance W.T.;Foley-Nelson T.;Thomas I.;Balasubramaniam A. 10-13-1997. Prevention of parenteral nutrition-induced gut hypoplasia by coinfusion of glucagon-like peptide-2 American Journal of Physiology - Gastrointestinal and Liver Physiology, 273 2 36-2, Estes A.M.;Wong Y.Y.;Parker M.S.;Sallee F.R.;Balasubramaniam A.;Parker S.L. 10-09-2008. Neuropeptide Y (NPY) Y2 receptors of rabbit kidney cortex are largely dimeric Regulatory Peptides, 150 1-3, 88-94Chance W.T.;Balasubramaniam A.;Thomas I.;Fischer J.E. 10-09-1992. Amylin increases transport of tyrosine and tryptophan into the brain Brain Research, 593 1, 20-24McDermott B.;Millar B.;Dolan F.;Bell D.;Balasubramaniam A. 10-08-1997. Evidence for Y<inf>1</inf> and Y<inf>2</inf> subtypes of neuropeptide Y rece European Journal of Pharmacology, 336 2-3, 257-265Wang B.;Sheriff S.;Balasubramaniam A.;Kennedy M. 10-07-2015. NMR based metabolomics study of Y2 receptor activation by neuropeptide Y in the SK-N-BE2 human neuro Metabolomics, 11 5, 1243-1252McLean L.;Best S.;Balasubramaniam A.;Jackson R. 10-03-1986. Fatty acyl chain specificity of phosphatidylcholine hydrolysis catalyzed by lipoprotein lipase. Effe Biochimica et Biophysica Acta (BBA)/Lipids and Lipid Metabolism, 878 3, 446-449Watanabe M.;Sheriff S.;Kadeer N.;Cho J.;Lewis K.;Balasubramaniam A.;Kennedy M. 10-01-2012. NMR based metabonomics study of NPY Y5 receptor activation in BT-549, a human breast carcinoma cell Metabolomics, 8 5, 854-868Shahab M.;Balasubramaniam A.;Sahu A.;Plant T. 10-01-2003. Central nervous system receptors involved in mediating the inhibitory action of neuropeptide Y on lu Journal of Neuroendocrinology, 15 10, 965-970Balasubramaniam A.;Sheriff S. 09-28-1990. Neuropeptide Y(18-36) is a competitive antagonist of neuropeptide Y in rat cardiac ventricular membr Journal of Biological Chemistry, 265 25, 14724-14727Chance W.;Sheriff S.;Kasckow J.;Regmi A.;Balasubramaniam A. 09-25-1998. NPY messenger RNA is increased in medial hypothalamus of anorectic tumor-bearing rats Regulatory Peptides, 75-76 , 347-353Sheriff S.;Dayal R.;Kasckow J.;Regmi A.;Chance W.;Fischer J.;Balasubramaniam A. 09-25-1998. NPY upregulates genes containing cyclic AMP response element in human neuroblastoma cell lines beari Regulatory Peptides, 75-76 , 309-318Chance W.;Balasubramaniam A.;Borchers M.;Fischer J. 09-11-1995. Refractory hypothalamic adenylate cyclase in anorectic tumor-bearing rats: implications for NPY-indu Brain Research, 691 1-2, 180-184Balasubramaniam A.;Tao Z.;Zhai W.;Stein M.;Sheriff S.;Chance W.;Fischer J.;Eden P.;Taylor J.;Liu C.;McFadden D.;Voisin T.;Roze C.;Laburthe M. 09-07-2000. Structure-activity studies including a ?(CH<inf>2</inf>-NH) scan of peptide YY (PYY) act Journal of Medicinal Chemistry, 43 18, 3420-3427Parker M.;Sah R.;Balasubramaniam A.;Sallee F.;Sweatman T.;Park E.;Parker S. 09-01-2008. Dimers of the neuropeptide Y (NPY) Y2 receptor show asymmetry in agonist affinity and association wi Journal of Receptors and Signal Transduction, 28 5, 437-451Balasubramaniam A. 09-01-2007. Editorial Current Topics in Medicinal Chemistry, 7 17, 1644Diccianni M.B.;Lilly-Stauderman M.;Harmony J.A.K.;McLean L.R.;Balasubramaniam A. 09-01-1991. Heparin Prevents the Binding of Phospholipase A<inf>2</inf> to Phospholipid Micelles: Im Biochemistry, 30 37, 9090-9097Balasubramaniam A.;Renugopalakrishnan V.;Rigel D.;Nussbaum M.;Rapaka R.;Dobbs J.;Carreira L.;Fischer J. 08-31-1989. Synthesis and biological properties of 4-norleucine-neuropeptide Y; secondary structure of neuropept Biochimica et Biophysica Acta (BBA)/Protein Structure and Molecular, 997 3, 176-181Chance W.;Sheriff S.;Moore J.;Peng F.;Balasubramaniam A. 08-24-1998. Reciprocal changes in hypothalamic receptor binding and circulating leptin in anorectic tumor-bearin Brain Research, 803 1-2, 27-33Chance W.;Tao Z.;Sheriff S.;Balasubramaniam A. 08-24-1998. Wryamide, a NPY-based tripeptide that antagonizes feeding in rats Brain Research, 803 1-2, 39-43McLean L.;Balasubramaniam A. 08-21-1992. Promotion of ?-structure by interaction of diabetes associated polypeptide (amylin) with phosphatidy Biochimica et Biophysica Acta (BBA)/Protein Structure and Molecular, 1122 3, 317-320Sheriff S.;Fischer J.;Balasubramaniam A. 08-12-1992. Amylin inhibits insulin-stimulated glucose uptake in C<inf>2</inf>C<inf>12</inf BBA - Molecular Cell Research, 1136 2, 219-222Sheriff S.;Qureshy A.;Chance W.;Kasckow J.;Balasubramaniam A. 07-30-2002. Erratum: Predominant role by CaM kinase in NPY Y<inf>1</inf> receptor signaling: Involve Peptides, 23 6, 1195Amoscato A.;Balasubramaniam A.;Wesley Alexander J.;Bebcock G. 07-20-1988. Degradation of thymopentin by human lymphocytes: evidence for aminopeptidase activity Biochimica et Biophysica Acta (BBA)/Protein Structure and Molecular, 955 2, 164-174Parker S.L.;Parker M.S.;Lundell I.;Balasubramaniam A.;Buschauer A.;Kane J.K.;Yalcin A.;Berglund M.M. 07-15-2002. Agonist internalization by cloned Y1 neuropeptide Y (NPY) receptor in Chinese hamster ovary cells sh Regulatory Peptides, 107 1-3, 49-62James J.H.;Wagner K.R.;King J.K.;Leffler R.E.;Upputuri R.K.;Balasubramaniam A.;Friend L.A.;Shelly D.A.;Paul R.J.;Fischer J.E. 07-01-1999. Stimulation of both aerobic glycolysis and Na<sup>+</sup>-K<sup>+</sup>-ATPa American Journal of Physiology - Endocrinology and Metabolism, 277 1 40-1, Balasubramaniam A.;Rechtin A.;McLean L.;Jackson R.;Demel R. 06-30-1986. Activation of lipoprotein lipase by N-?-palmitoyl (56-79) fragment of apolipoprotein C-II Biochemical and Biophysical Research Communications, 137 3, 1041-1048Balasubramaniam A. 06-09-1997. Neuropeptide Y family of hormones: Receptor subtypes and antagonists Peptides, 18 3, 445-457Chance W.;Balasubramaniam A.;Sheriff S. 06-04-2003. Neuropeptide Y and cancer anorexia Current Medicinal Chemistry - Central Nervous System Agents, 3 2, 127-139Chance W.;Zhang X.;Zuo L.;Balasubramaniam A. 06-01-1998. Reduction of gut hypoplasia and cachexia in tumor-bearing rats maintained on total parenteral nutrit Nutrition, 14 6, 502-507Parker E.;Babij C.;Balasubramaniam A.;Burrier R.;Guzzi M.;Hamud F.;Gitali Mukhopadhyay;Rudinski M.;Tao Z.;Tice M.;Xia L.;Mullins D.;Salisbury B. 05-15-1998. GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y European Journal of Pharmacology, 349 1, 97-105Balasubramaniam A.;Dhawan V.;Mullins D.;Chance W.;Sheriff S.;Guzzi M.;Prabhakaran M.;Parker E. 05-10-2001. Highly selective and potent neuropeptide Y (NPY) Y1 receptor antagonists based on [Pro<sup>30& Journal of Medicinal Chemistry, 44 10, 1479-1482Parker S.L.;Parker M.S.;Estes A.M.;Wong Y.Y.;Sah R.;Sweatman T.;Park E.A.;Balasubramaniam A.;Sallee F.R. 05-01-2008. The neuropeptide Y (NPY) Y2 receptors are largely dimeric in the kidney, but monomeric in the forebr Journal of Receptors and Signal Transduction, 28 3, 245-263Conlon J.M.;Balasubramaniam A.;Hazon N. 05-01-1991. Structural characterization and biological activity of a neuropeptide Y-related peptide from the dog Endocrinology, 128 5, 2273-2279Chance W.;Zhang X.;Balasubramaniam A.;Fischer J. 04-19-1996. Preservation of intestine protein by peptide YY during total parenteral nutrition Life Sciences, 58 21, 1785-1794Chance W.;Balasubramaniam A.;Stallion A.;Fischer J. 04-02-1993. Anorexia following the systemic injection of amylin Brain Research, 607 1-2, 185-188Jois S.;Nagarajarao L.;Prabhakaran M.;Balasubramaniam A. 04-01-2006. Modeling of neuropeptide receptors Y1, Y4, Y5, and docking studies with neuropeptide antagonist anal Journal of Biomolecular Structure and Dynamics, 23 5, 497-508Balasubramaniam A.;Zhai W.;Sheriff S.;Tao Z.;Chance W.;Fischer J.;Eden P.;Taylor J. 03-08-1996. Bis(31/31'){[Cys<sup>31</sup>,Trp<sup>32</sup>,Nva<sup>34</sup>] Journal of Medicinal Chemistry, 39 4, 811-813Parker M.;Balasubramaniam A.;Sallee F.;Parker S. 03-07-2018. The expansion segments of 28S Ribosomal RNA extensively match human messenger RNAs Frontiers in Genetics, 9 MAR, Parker S.;Parker M.;Sah R.;Sallee F.;Balasubramaniam A. 03-01-2007. Parallel inactivation of Y<inf>2</inf> receptor and G-proteins in CHO cells by pertussis Regulatory Peptides, 139 1-3, 128-135Parker E.;Balasubramaniam A.;Guzzi M.;Mullins D.;Salisbury B.;Sheriff S.;Witten M.;Hwa J. 03-01-2000. [D-Trp<sup>34</sup>] neuropeptide Y is a potent and selective neuropeptide Y Y<inf> Peptides, 21 3, 393-399Balasubramaniam A.;Ujhelyi M.;Borchers M.;Huang Y.;Zhai W.;Zhou Y.;Johnson M.;Sheriff S.;Fischer J.E. 03-01-1996. Antagonistic properties of centrally truncated analogs of [D-Trp<sup>32</sup>]NPY Journal of Medicinal Chemistry, 39 5, 1142-1147Balasubramaniam A.;Sheriff S.;Johnson E.;Prabhakaran M.;Huang Y.;Fischer J.;Chance W. 03-01-1994. [d-TRP<sup>32</sup>]Neuropeptide Y: A Competitive Antagonist of NPY in Rat Hypothalamus Journal of Medicinal Chemistry, 37 6, 811-815Michael Conlon J.;Balasubramaniam A.;Sower S. 02-24-1994. Purification of a neuropeptide Y-related peptide from the brain of the sea lamprey and its effect on Regulatory Peptides, 50 2, 167-175Jackson R.;Balasubramaniam A.;Murphy R.;Demel R. 02-12-1986. Interaction of synthetic peptides of apolipoprotein C-II and lipoprotein lipase at monomolecular lip Biochimica et Biophysica Acta (BBA)/Lipids and Lipid Metabolism, 875 2, 203-210Parker M.;Sah R.;Balasubramaniam A.;Sallee F.;Zerbe O.;Parker S. 02-01-2011. Non-specific binding and general cross-reactivity of y receptor agonists are correlated and should i Peptides, 32 2, 258-265Parker S.;Parker M.;Sah R.;Balasubramaniam A.;Sallee F. 02-01-2007. Self-regulation of agonist activity at the Y receptors Peptides, 28 2, 203-213Sheriff S.;Chance W.T.;Iqbal S.;Rizvi T.A.;Xiao C.;Kasckow J.W.;Balasubramaniam A. 02-01-2003. Hypothalamic administration of cAMP agonist/PKA activator inhibits both schedule feeding and NPY-ind Peptides, 24 2, 245-254Chance W.T.;Balasubramaniam A.;Zhang F.S.;Wimalawansa S.J.;Fischer J.E. 01-25-1991. Anorexia following the intrahypothalamic administration of amylin Brain Research, 539 2, 352-354Gangadhar B.P.;Jois S.D.S.;Balasubramaniam A. 01-05-2004. Convenient high yield and stereoselective synthesis of O-glycopeptides using N-?-Fmoc-Tyr/Ser[?-D-Gl Tetrahedron Letters, 45 2, 355-358Parker M.;Sah R.;Park E.;Sweatman T.;Balasubramaniam A.;Sallee F.;Parker S. 01-01-2009. Oligomerization of the heptahelical G protein coupling receptors: A case for association using trans Mini-Reviews in Medicinal Chemistry, 9 3, 329-339Parker S.;Balasubramaniam A. 01-01-2008. Neuropeptide Y Y2 receptor in health and disease British Journal of Pharmacology, 153 3, 420-431Jois S.;Nagarajarao L.;Prabhakaran M.;Balasubramaniam A. 01-01-2004. Modeling of neuropeptide receptors y1, y4, y5, and docking studies with neuropeptide antagonist anal Journal of Biomolecular Structure and Dynamics, 22 1, 497-508Goumain M.;Voisin T.;Lorinet A.;Ducroc R.;Tsocas A.;Rozé C.;Rouet-Benzineb P.;Herzog H.;Balasubramaniam A.;Laburthe M. 01-01-2001. The peptide YY-preferring receptor mediating inhibition of small intestinal secretion is a periphera Molecular Pharmacology, 60 1, 124-134Sheriff S.;Dautzenberg F.;Mulchahey J.;Pisarska M.;Hauger R.;Chance W.;Balasubramaniam A.;Kasckow J. 01-01-2001. Interaction of neuropeptide Y and corticotropin-releasing factor signaling pathways in AR-5 amygdala Peptides, 22 12, 2083-2089Chance W.;Sheriff S.;Peng F.;Balasubramaniam A. 01-01-2000. Antagonism of NPY-induced feeding by pretreatrnent with cyclic AMP response element binding protein Neuropeptides, 34 3-4, 167-172Chance W.T.;Sheriff S.;Foley-Nelson T.;Thomas I.;Balasubramaniam A. 01-01-2000. Maintaining gut integrity during parenteral nutrition of tumor-bearing rats: Effects of glucagon-lik Nutrition and Cancer, 37 2, 215-222Sheriff S.;Chance W.T.;Balasubramaniam A. 01-01-2000. Antisense oligonucleotide approach to study NPY-mediated feeding signal transduction. Methods in molecular biology (Clifton, N.J.), 153 , 103-114Litvak D.;Iseki H.;Evers B.;Greeley G.;Hellmich M.;Iwase K.;Balasubramaniam A.;Townsend C. 01-01-1999. Characterization of two novel proabsorptive peptide YY analogs, BIM- 43073D and BIM-43004C Digestive Diseases and Sciences, 44 3, 643-648Mulchahey J.;Regmi A.;Sheriff S.;Balasubramaniam A.;Kasckow J. 01-01-1999. Coordinate and divergent regulation of corticotropin-releasing factor (CRF) and CRF-binding protein Endocrinology, 140 1, 251-259Samarasinghe S.;Balasubramaniam A.;Johnson M. 01-01-1997. Proton nuclear magnetic resonance studies of the structure of neuropeptide Y and its analogs Current Medicinal Chemistry, 4 2, 151-158Sheriff S.;Chance W.;Fischer J.;Balasubramaniam A. 01-01-1997. Neuropeptide Y treatment and food deprivation increase cyclic AMP response element-binding in rat hy Molecular Pharmacology, 51 4, 597-604Souli A.;Chariot J.;Voisin T.;Presset O.;Tsocas A.;Balasubramaniam A.;Laburthe M.;Rozé C. 01-01-1997. Several receptors mediate the antisecretory effect of peptide YY, neuropeptide Y, and pancreatic pol Peptides, 18 4, 551-557Chance W.;Balasubramaniam A.;Thompson H.;Mohapatra B.;Ramo J.;Fischer J. 01-01-1996. Assessment of feeding response of tumor-bearing rats to hypothalamic injection and infusion of neuro Peptides, 17 5, 797-801Huang Y.;Fischer J.E.;Balasubramaniam A. 01-01-1996. Amylin mobilizes [Ca<sup>2+</sup>]<inf>i</inf> and stimulates the release of Peptides, 17 3, 497-502Liu C.;Rongione A.;Garvey L.;Balasubramaniam A.;McFadden D. 01-01-1996. Adjuvant hormonal treatment with peptide YY or its analog decreases human pancreatic carcinoma growt American Journal of Surgery, 171 1, 192-196Chance W.;Balasubramaniam A.;Fischer J. 01-01-1995. Neuropeptide Y and the development of cancer anorexia Annals of Surgery, 221 5, 579-589Clay M.;Anantharamaiah M.;Mistry M.;Balasubramaniam A.;Harmony J. 01-01-1995. Localization of a Domain in Apolipoprotein E with both Cytostatic and Cytotoxic Activity Biochemistry, 34 35, 11142-11151Eto B.;Boisset M.;Eden P.;Balasubramaniam A.;Desjeux J. 01-01-1995. Effects of peptide YY and its analogues on chloride ion secretion in fed and fasted rat jejunum Peptides, 16 8, 1403-1409Liu C.;Balasubramaniam A.;Saxton R.;Paiva M.;McFadden D. 01-01-1995. Human pancreatic cancer growth is inhibited by peptide YY and BIM-43004-1 Journal of Surgical Research, 58 6, 707-712Liu C.;Slice L.;Balasubramaniam A.;Walsh J.;Newton T.;Saxton R.;McFadden D. 01-01-1995. Y2 receptors decrease human pancreatic cancer growth and intracellular cyclic adenosine monophosphat Surgery, 118 2, 229-236Lui C.;Hines O.;Whang E.;Balasubramaniam A.;Newton T.;Zinner M.;Ashley S.;McFadden D. 01-01-1995. A novel synthetic analog of peptide YY, BIM-43004, given intraluminally, is proabsorptive Journal of Surgical Research, 59 1, 80-84Chance W.;Balasubramaniam A.;Dayal R.;Brown J.;Fischer J. 01-01-1994. Hypothalamic concentration and release of neuropeptide Y into microdialysates is reduced in anorecti Life Sciences, 54 24, 1869-1874Chance W.T.;Balasubramaniam A.;Sheriff S.;Fischer J.E. 01-01-1994. Possible role of neuropeptide Y in experimental cancer anorexia Advances in Experimental Medicine and Biology, 354 , 185-201Balasubramaniam A.;Cox H.;Voisin T.;Laburthe M.;Stein M.;Fischer J. 01-01-1993. Structure-activity studies of peptide YY(22-36): N-?-Ac-[Phe<sup>27</sup>]PYY(22-36), a Peptides, 14 5, 1011-1016Bjenning C.;Hazon N.;Balasubramaniam A.;Holmgren S.;Conlon J.M. 01-01-1993. Distribution and activity of dogfish NPY and peptide YY in the cardiovascular system of the common d American Journal of Physiology - Regulatory Integrative and Comparative Physiology, 264 6 33-6, Lilly-Stauderman M.;Brown T.;Balasubramaniam A.;Harmony J. 01-01-1993. Heparin releases newly synthesized cell surface-associated apolipoprotein E from HepG2 cells Journal of Lipid Research, 34 2, 190-200Wadhwa S.;Jotwani G.;Balasubramaniam A. 01-01-1993. Development of neuropeptide Y-like immunoreactivity in the rat heart Acta Histochemica et Cytochemica, 26 3, 227-232Balasubramaniam A.;Rigel D.;Chance W.;Fischer J. 01-01-1992. Central and peripheral effects of sculpin pancreatic polypeptide and anglerfish peptide Y in rats. Peptide research, 5 2, 106-109Chance W.;Balasubramaniam A.;Chen X.;Fischer J. 01-01-1992. Tests of adipsia and conditioned taste aversion following the intrahypothalamic injection of amylin Peptides, 13 5, 961-964Inui A.;Okita M.;Miura M.;Hirosue Y.;Nakajima M.;Shii K.;Baba S.;Balasubramaniam A.;Kasuga M. 01-01-1992. Solubilization of high affinity peptide-YY receptors from porcine brain Endocrinology, 130 4, 2120-2128Sheriff S.;Balasubramaniam A. 01-01-1992. Inhibitory and stimulatory effects of neuropeptide Y(17-36) on rat cardiac adenylate cyclase activit Journal of Biological Chemistry, 267 7, 4680-4685Sheriff S.;Fischer J.;Balasubramaniam A. 01-01-1992. Characterization of amylin binding sites in a human hepatoblastoma cell line Peptides, 13 6, 1193-1199Balasubramaniam A.;Renugopalakrishnan V.;Stein M.;Fischer J.;Chance W. 01-01-1991. Syntheses, structures and anorectic effects of human and rat amylin Peptides, 12 5, 919-924Mcfadden D.;Rudnicki M.;Balasubramaniam A.;Fischer J. 01-01-1991. Intraluminal Heal Recovery of Pancreatic Polypeptide Archives of Surgery, 126 8, 1032-1035Balasubramaniam A.;Rigel D.F.;Chance W.T.;Stein M.;Fischer J.E.;King D.;Plisetskaya E.M. 01-01-1990. Salmon pancreatic polypeptide exhibits neuropeptide Y-like activities in rats Peptides, 11 4, 673-677Balasubramaniam A.;Sheriff S.;Ferguson D.G.;Stein M.;Rigel D.F. 01-01-1990. N-?-biotinylated-neuropeptide Y analogs: Syntheses, cardiovascular properties, and application to ca Peptides, 11 6, 1151-1156BALASUBRAMANIAM A.;SHERIFF S.;RENUGOPALAKRISHNAN V.;HUANG S.;PRABHAKARAN M.;CHANCE W.;FISCHER J. 01-01-1990. Cardiac Properties and Conformational Studies of Neuropeptide Y (NPY) and NPY(17–36) Annals of the New York Academy of Sciences, 611 1, 355-358Balasubramaniam A.;Sheriff S.;Rigel D.F.;Fischer J.E. 01-01-1990. Characterization of neuropeptide Y binding sites in rat cardiac ventricular membranes Peptides, 11 3, 545-550CHANCE W.T.;RAMO J.;SHERIFF S.;ZHANG F.;FISCHER J.E.;BALASUBRAMANIAM A. 01-01-1990. Reduction of Neuropeptide Y?Induced Feeding in Tumor?Bearing Rats Annals of the New York Academy of Sciences, 611 1, 497-499Rämö O.;Balasubramaniam A.;Sheriff S.;Rogers D.;McCullough P.;Bell R. 01-01-1990. Neuropeptide Y and peptide YY stimulate the growth of exocrine pancreatic carcinoma cells Neuropeptides, 15 2, 101-106Rudnicki M.;McFadden D.;Balasubramaniam A.;Nussbaum M.;Fischer J. 01-01-1990. The postprandial circulatory and lleal intraluminal release of neuropeptide Y in conscious dogs Journal of Surgical Research, 49 6, 514-518RUDNICKI M.;McFADDEN D.;BALASUBRAMANIAM A.;NUSSBAUM M.;FISCHER J. 01-01-1990. Neuropeptide Y and Anglerfish Peptide Amide Inhibit Secretin?Stimulated Pancreatic Exocrine Secretio Annals of the New York Academy of Sciences, 611 1, 423-425Rudnicki M.;McFadden D.;Liwnicz B.;Balasubramaniam A.;Nussbaum M.;Dayal R.;Fischer J. 01-01-1990. Endogenous peptide YY is dependent on jejunal exposure to gastrointestinal contents Journal of Surgical Research, 48 5, 485-490Rudnicki M.;Patel D.G.;McFadden D.W.;Balasubramaniam A.;Nussbaum M.S.;Fischer J.E. 01-01-1990. Proximal jejunal and biliary effects on the enteroinsular axis Surgery, 107 4, 455-460Sheriff S.;Rigel D.;Fischer J.;Balasubramaniam A. 01-01-1990. Interaction of <sup>125</sup>I-Neuropeptide Y with rat cardiac membranes Neuropeptides, 15 3, 157-160Balasubramaniam A.;Andrews P.C.;Renugopalakrishnan V.;Rigel D.F. 01-01-1989. Glycine-extended anglerfish peptide YG (aPY) a neuropeptide Y (NPY) homologue may be a precursor of Peptides, 10 3, 581-585BALASUBRAMANIAM A.;KNITTEL J.J.;GILL C.;ANDREWS P.C. 01-01-1989. Detection of conformational isomers of anglerfish peptide YG (aPY) by reversed phase chromatography International Journal of Peptide and Protein Research, 34 2, 158-160Balasubramaniam A.;McFadden D.;Rudnicki M.;Nussbaum M.;Dayal R.;Srivastava L.;Fischer J. 01-01-1989. Radioimmunoassay to determine postprandial changes in plasma Neuropeptide Y levels in awake dogs Neuropeptides, 14 3, 209-212Chance W.T.;Sheriff S.;Foley-Nelson T.;Fischer J.E.;Balasubramaniam A. 01-01-1989. Pertussis toxin inhibits neuropeptide Y-induced feeding in rats Peptides, 10 6, 1283-1286McFadden D.;Rudnicki M.;Nussbaum M.;Balasubramaniam A.;Fischer J. 01-01-1989. Independent release of peptide YY (PYY) into the circulation and ileal lumen of the awake dog Journal of Surgical Research, 46 4, 380-385Milgram S.;Balasubramaniam A.;Andrews P.;McDonald J.;Noe B. 01-01-1989. Characterization of aPY-like peptides in anglerfish brain using a novel radioimmunoassay for aPY-Gly Peptides, 10 5, 1013-1017Noe B.;Milgram S.;Balasubramaniam A.;Andrews P.;Calka J.;McDonald J. 01-01-1989. Localization and characterization of neuropeptide Y-like peptides in the brain and islet organ of th Cell and Tissue Research, 257 2, 303-311Renugopalakrishnan V.;Prabhakaran M.;Huang S.;Balasubramaniam A.;Strawich E.;Glimcher M. 01-01-1989. Secondary structure and limited three-dimensional structure of bovine amelogenin Connective Tissue Research, 22 1-4, 757-764Rigel D.;Grupp I.;Balasubramaniam A.;Grupp G. 01-01-1989. Contractile effects of cardiac neuropeptides in isolated canine atrial and ventricular muscles American Journal of Physiology - Heart and Circulatory Physiology, 257 4, Servin A.L.;Rouyer-Fessard C.;Balasubramaniam A.;Pierre S.S.;Laburthe M. 01-01-1989. Peptide-yy and neuropeptide-y inhibit vasoactive intestinal peptide-stimulated adenosine 3', 5'-mono Endocrinology, 124 2, 692-700Balasubramaniam A.;Grupp I.;Matlib M.;Benza R.;Jackson R.;Fischer J.;Grupp G. 01-01-1988. Comparison of the effects of neuropeptide Y (NPY) and 4-norleucine-NPY on isolated perfused rat hear Regulatory Peptides, 21 3-4, 289-299Balasubramaniam A.;Servin A.L.;Rigel D.F.;Rouyer-Fessard C.R.;Laburthe M. 01-01-1988. Syntheses and receptor affinities of partial sequences of peptide YY (PYY). Peptide research, 1 1, 32-35McFadden D.;Nussbaum M.;Rudnicki M.;Balasubramaniam A.;Fischer J. 01-01-1988. Postprandial neuropeptide Y release in the conscious dog Surgical Forum, 39 , 143-145Balasubramaniam A.;Chopra Y.;Yates M.;Jackson R. 01-01-1987. Total synthesis of human plasma apolipoprotein C-II Bioorganic Chemistry, 15 2, 141-151BALASUBRAMANIAM A.;GRUPP I.;SRIVASTAVA L.;TATEMOTO K.;MURPHY R.F.;JOFFE S.N.;FISCHER J.E. 01-01-1987. Synthesis of neuropeptide Y International Journal of Peptide and Protein Research, 29 1, 78-83Clark J.;Sahu A.;Kalra P.;Balasubramaniam A.;Kalra S. 01-01-1987. Neuropeptide Y (NPY)-induced feeding behavior in female rats: comparison with human NPY ([Met<sup Regulatory Peptides, 17 1, 31-39Sahu A.;Crowley W.;Tatemoto K.;Balasubramaniam A.;Kalra S. 01-01-1987. Effects of neuropeptide Y, NPY analog (norleucine<sup>4</sup>-NPY), galanin and neuropep Peptides, 8 5, 921-926Balasubramaniam A.;Demel R.;Murphy R.;Sparrow J.;Jackson R. 01-01-1986. Substitution of SER<inf>61</inf> ? GLY<inf>61</inf> in human apolipoprotein Chemistry and Physics of Lipids, 39 4, 341-346BALASUBRAMANIAM A.;MURPHY R.;BLUMENTHAL K. 01-01-1986. Synthesis of sequences 1–16 and 63–95 of Cerebratulus lacteus toxin AIII: Hemolytic activity in a to International Journal of Peptide and Protein Research, 27 5, 508-513